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Abstract 
Central-line-associated bloodstream infections (CLABSIs) occur during the insertion or 
change of the dressing of the central venous catheter (CVC) and are reportable health-
care-associated infections at the state and the national level. The purpose of this 
systematic review of the literature was to evaluate and synthesize available evidence to 
establish the effectiveness of using an adhesive transparent chlorohexidine gluconate 
(CHG) Tegaderm™ gel dressing for CVC in the prevention of CLABSIs. The logic 
model was used as a framework to guide the review of the literature to establish how an 
intervention that is not currently practiced can contribute to CVC prevention of infection. 
The practice question focused on gathering evidence to support the effects of CHG 
Tegaderm™ gel central-line dressing compared with the Biopatch® dressing. A total of 
373 articles were retrieved and 16 met the inclusion for review and were graded 
according to the Melnyk and Fineout-Overholt hierarchy level of evidence and evidence 
synthesis broken down into the reduction of CLABSI, the cost-effectiveness and ease of 
use of the CHG Tegaderm™ gel. Findings from the systematic review supported the use 
of CHG gel dressing as a CLABSI preventative measure. The findings from the project 
support positive social change by reducing CLABSI and associated illnesses and saving 
the increased cost, mortality, and morbidity associated with CLABSIs. 
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Section 1: Nature of the Project 
Introduction 
A central line-associated bloodstream infection (CLABSI) occurs when germs 
enter the bloodstream through an inserted catheter in the large vein in the neck, chest, or 
groin to give medications or fluids or collect blood for medical tests. They are inserted in 
the major veins that are close to the heart and can remain in the place for weeks or 
months. Because of the proximity to the heart, they a have high likelihood of causing an 
infection known as a CLASBI. The infection of the central line can occur during the 
insertion of the central line or while caring for the central line site during the check or 
change of the dressing. CLABSI results in deaths of thousands of patients each year and 
billions of dollars are added to the United States health care cost burden. CLABSIs are 
deemed to be preventable nosocomial infections if guidelines, tools, and protocols are 
adhered to (Healthcare-Associated Infections, 2010). CLABSIs results in thousands of 
deaths each year resulting in the loss of lives and increase in the billions of dollars spent. 
To decrease the rate of CLABSIs, nurses and health care team need to address and have a 
quality improvement intervention that will be practical and efficient. Therefore, having 
an intervention that is tailored to the reduction of CLABSI will be beneficial in the fight 
of the deadly disease known as CLABSIs (Williamson, Neusbaum, & Messing, 2017). 
Nature of the Doctoral Project 
The practice problem involved the systematic review of the effectiveness of using 
the adhesive transparent chlorohexidine gluconate Tegaderm™ gel for adults older than 
18 years admitted to the critical care unit with the central venous catheter. In my project, 
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I searched published literature for credible evidence to validate the use of adhesive 
transparent chlorohexidine gluconate Tegaderm™ gel for central venous catheter 
dressings as an evidence-based treatment modality to decrease the CLASBI rate. My 
project involved surveying the current literature to identify the empirical evidence 
available of how the use of the adhesive transparent chlorohexidine gluconate 
Tegaderm™ is superior for reducing the CLABSIs and make recommendations to the 
local acute hospital. I conducted a systematic literature review to validate the research 
question to recommend the findings of the evidence-based practice from published 
literature from credible databases and Google Scholar. 
Positive Social Change  
The recommendations of the Tegaderm™ CHG can have a positive impact on 
social change in the society and the healthcare at large. Patients are less likely to survive 
when they develop CLABSI, especially if there is an already a disease that has weakened 
the immune system. Having a dressing that will prevent central line infection will 
promote the well-being of the patients and decreases chances of mortality, hence saving 
lives. On the economic perspective, the Tegaderm™ CHG has economic benefits not 
only to the facility but also to the health care at large. When patients develop, an infection 
related to the central line catheter, the financial toll is passed to the hospital and the 
taxpayers. Reducing the amount of money that is spent on health-care-associated 
infections can be channeled to other social services that will improve citizens’ lives, thus 
contributing to the positive social change that aligns with Walden’s vision for positive 
social change (Walden 2020, n.d). 
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Problem Statement 
Local Nursing Practice Problem  
Central venous catheters are widely used in intensive care units and acute care to 
administer drugs or fluids. The populations in adult intensive care units are critically ill 
and susceptible to infection. When catheters are introduced into the patients’ bodies, they 
become an easy port of bacterial entry if proper care is not taken. The use of Biopatch® 
with central line dressing has been widely used for years, but the CLABSIs rates are still 
high. There is a new intervention that has emerged using Tegaderm™ with CHG gel, 
which is transparent and adhesively secures the central line site and allows the clinicians 
to view the site. The dressing acts as a barrier against external contamination, and the gel 
pad has an antiseptic agent. The water-vapor-permeable CHG-impregnated gel pad is 
incorporated onto the adhesive side of a transparent polyurethane dressing, and the CHG-
impregnated gel pad is applied directly over the insertion site at the time of catheter 
insertion or during follow up site care. The gel rapidly softens at skin temperatures and 
flows about the catheter, providing intimate contact of the CHG-impregnated surface 
with the entire insertion site. The gel also absorbs up to eight times its weight in fluid, 
preventing accumulation of moisture on the site. The integrated dressing tightly secures 
the catheter, preventing any positioning movement that can facilitate entry of 
microorganism into the insertion tract. (Maki, Stahl, Jacobson, & Pyrek, 2008). Patients 
who have central venous catheters or arterial line catheters are critically ill and are 
susceptible to developing CLABSIs due to microorganisms that can be formed during the 
insertion, during use, dressing change, or spread from another source. The use of CHG-
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impregnated dressing placed during the time of CVC insertion and dressing changes 
ensures the dressing to release the chlorhexidine onto the skin for a 10-day period. 
Local Relevance 
The decrease in CLABSIs is essential for nursing practice especially with a 
facility that is aiming for magnet designation and to decrease the mortality and morbidity 
associated with CLABSI. Money that spent on treating CLABSI can be used to buy state 
of the art equipment that facilitates a favorable environment for nursing staff. 
Tegaderm™ CHG is easier to use and reduces the rate of infection. The local facility is 
targeting to transition from the standard CVC dressing with Biopatch® to the 
Tegaderm™ CHG gel if enough evidence exists to convince hospital leadership that the 
latter is better than the current dressing. Also, the goal of the local critical care unit is to 
have decreased numbers of CLABSIs per 1,000 central line days. The nursing goal is to 
provide a nurturing and healing environment that restores the well-being of the patients. 
The local hospital applies the 2011 Centers for Disease Control (CDC) guidelines with an 
aim in preventing the CLABSI. After the central line insertion or during the dressing 
change, a chlorhexidine impregnated sponge (Biopatch®) is applied at the site of 
insertion and covered with a sterile, transparent, semipermeable dressing per the 2011 
CDC guidelines (CDC, n.d.). Despite adhering to the CDC guidelines on the care of 
central venous catheter, the facility continues to have high numbers of CLABSIs. 
Significance to Nursing Practice 
Decreasing the rate of infections is a paramount goal that each nurse and the 
whole nursing profession aim to increase the safety and health outcome. The doctoral 
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systematic review project yielded evidence-based data that can be implemented by the 
local critical care unit or other units in the local hospital and in the field of nursing 
practice. The systematic review was used to establish the validity of this proposed 
treatment modality to decrease CLASBIs. The completed extensive systematic review of 
the literature yielded the highest level of evidence to support the practice, thus build more 
trust and buy-in of the use of CHG Tegaderm™ in CLABSI prevention (Jenks et al., 
2016). Nurses are at the forefront in implementing evidence-based practice in the 
improvement of patients care outcome and decrease the cost of health care. In this 
essence, the use of a dressing that is tailored in the reduction of CLABSI can have a 
significant influence in patients’ safety and health care costs, and it can add knowledge to 
the body of nursing on the best intervention based on the available highest level of 
evidence to support the proposed treatment modality. By conducting this systematic 
review, the evidence obtained that is highly ranked on the hierarchy pyramid of evidence 
is clear that the use of evidence-based interventions is a pillar in the growth of nursing. 
Therefore, the evidence obtained clearly and strongly supports the proposed treatment 
modality (Stango, Runyan, Stern, Macri, & Vacca, 2014). 
Purpose Statement 
CLABSIs are one of the lists of diagnosis that are deemed by the Centers for 
Medicare and Medicaid Services’ (CMS) as the list of nonpayable preventable hospital-
acquired conditions. CLABSIs cases are costly with a case being estimated to cost 
$25,000 to $32,000. The cost burden is left on the healthcare organization to bear. 
Healthcare facilities continue to invest time and resources to reduce CLABSIs, and yet it 
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continues to be a challenge (Strickler, Gupta, Doucette, & Kohli-Seth, 2018). 
Approximately 250, 000 bloodstream infections occur annually with most of them related 
to intravascular devices. The CLABSI rates in the United States intensive care units are 
estimated to be 0.8 per 1000 of central line days (Jackson & Davies, 2015). The local 
critical care unit has current CLABSI rate of 0.962 and the whole hospital has a CLABSI 
rate of 1.232 for the current fiscal year starting October 1, 2017, to September 30, 2018. 
The critical care leadership in the local hospital has identified the following needs: 
1. To decrease the numbers of CLABSIs per 1000 central line days.  
2. To achieve the target goal 0.641 per fiscal year. 
Despite the guidelines for central line insertion and central line maintenance, 
CLABSI rates remain a challenge in health care. Being one of the nonpayable hospital-
acquired conditions, it is important for the hospitals to manage to eliminate the cases of 
CLABSIs if possible, to save dollars and lives. My purpose in this systematic review was 
to evaluate and synthesize the available evidence-based research on the use of adhesive 
transparent CHG Tegaderm™ in the reduction of CLABSIs in the central venous 
catheter. The anticipated outcome of conducting this systematic review was to yield 
evidence that will support the need of implementing the proposed treatment intervention 
with an aim in decreasing the rates of CLASBIs and to fill the gap in nursing practice on 
the best method or effective method to reduce CLABSIs cases. 
Gap in Practice 
The reduction of CLABSI is an area that many hospitals are still struggling to 
control. The local hospital still has struggles with CLABSIs with most time doing worse 
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than the national average. The critical care leadership team anticipates a decrease in the 
rate of CLABSIs with the introduction of CHG Tegaderm™ instead of the traditional 
Biopatch® dressing based on the available evidence to prove that the use of CHG gel 
dressing is superiors and economical to the use of standard dressing with Biopatch® as 
currently being used if approved by the administration. With increasing need to provide 
the highest quality and minimize the rate of central line infections, the gap in nursing on 
the reduction of CLABSIs still exists on the best highest quality method that can be used 
to decrease or have zero chances of CLABSIs. My purpose in this systematic review of 
the literature was to evaluate why the use of transparent IV dressing with CHG gel is 
essential to reduce the infection compared to the standard CVC dressing with Biopatch® 
during the insertion and dressing changes. The results of the systematic review will be 
essential to the facility and the nursing practice to contribute how the deadly disease can 
be prevented and how nurses can contribute to the quality improvement process of a 
hospital to improve patients’ outcome. The results create wealth of knowledge in nursing 
practice through synthesizing of broad evidence for quick reference to back the 
implementation and provision of care guided by the current and strongest evidence from 
credibly published literature.  
Practice-Focused Question 
The practice-focused question in my study was: “Does the use of adhesive 
transparent chlorohexidine gluconate gel Tegaderm™ for adults above 18 years of age 
admitted to acute and critical care unit with the central venous catheter decrease the 
central line- CLABSIs rate?” 
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Addressing the Gap in Practice 
By addressing this systematic review, the results of the review addressed the gap 
in the need of finding the best solution for decreasing the rate of CLABSI. The use of 
transparent intravenous (IV) dressing with CHG gel pad is considered superior to the 
standard transparent dressing with Biopatch® because it reduces the rate of infections, 
allows easy access to the insertion site, and is deemed to be easy to use by nursing staff. 
The evidence obtained has proven that for the facility to achieve the target of decreasing 
the rate of CLABSIs, the CHG gel dressing should be implemented together with other 
central line care bundles. Facilities that were using Biopatch® before conducting the 
studies of how effective the use of CHG gel is compared to the standard dressing or the 
use of Biopatch® revealed that the use of CHG gel can and will decrease the rate of 
CLABSIs compared with the other dressings. For instance, in a study that was done in a 
critical care unit for nine months of the use of CHG Tegaderm™ dressing, 70 of 81 
subjects interviewed indicated that they prefer the dressing compared to the standard 
dressing (Karpanen et al., 2016). The staff also considered the dressing more 
straightforward to use, and 77 of the respondents in the survey recommended for future 
use compared to the standard dressing they were using before (Karpanen et al., 2016). 
The CDC and the CDC’s Healthcare Infection Control Practices Advisory Committee 
(HICPAC) recently approved and recommended the use of Chlorhexidine-impregnated 
dressings for the central venous catheters because of their barrier to prevent bacterial 
penetration to catheter site preventing CLABSIs. The recommendation is based on the 
systematic review of the literature, quality of evidence, and infection rate. The dressing 
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should be for only adults 18 years and older. It should be chlorhexidine-impregnated 
dressings with a U.S. Food and Drug Administration (FDA)-cleared label as is indicated 
to reduce CLABSIs and recommended to protect the insertion site (Public Relations 
Newswire, 2017). 
Nature of the Doctoral Project 
Sources of Evidence and Approach 
The systematic review involved reviewing evidence after a clear formulated 
clinical question was developed. The question helped to identify, select and appraise 
relevant published literature to collect data from the reviewed studies. The process that I 
used was a systematic approach to avoid any biases, random errors, arbitrariness, and 
personal opinions. The systematic review process involved setting clear objectives that 
had predefined eligibility criteria for the study after identifying a methodology for the 
study. The eligibility criteria were set to aid in the systematic search of the literature. I 
followed the systematic review steps as noted in the Walden DNP systematic review 
manual (Walden University Manual for Systematic Review, 2017). I used the Walden 
University manual for systematic review and used Walden University library and Google 
Scholar while conducting the systematic review of the literature for the above DNP 
project. I obtained researched articles from the sources such as Cochrane Database of 
Systematic Reviews (CDSR), National Library of Medicine (NLM), PubMed Health, 
Biomed Central, Cumulative Index to Nursing & Allied Health Literature (CINAHL), 
Joanna Briggs Institute EBP Database, ProQuest Nursing and Allied Health Source 
database, and Google Scholar. The search words used included central venous catheter, 
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Tegaderm™ CHG, standard intravenous dressing, adult critical care, bloodstream 
infection, chlorhexidine gel dressing, and catheter-related bloodstream infection 
(CRBSI). 
The inclusion criteria included only articles published within ten years and 
published in the English language, randomized controlled trials, and nonrandomized 
controlled clinical trials. All other research methods were excluded. The demographic 
characteristics of the population that qualified for inclusion included adults older than 18 
years, adults admitted in acute and intensive care units, nurses taking care of the adult 
critically ill patients. The exclusion criteria were patients with already existing 
bloodstream infections and patients younger than 18 years. 
Approach to Organize and Analyze the Evidence 
I organized the evidence obtained after searching the literature in the Microsoft 
Word matrix table and created an evidence summary table from each selected study. I 
used the level of evidence using Melnyk-Fineouts’ hierarchy pyramid (Melnyke & 
Fineout-Overholt, 2011) to grade the evidence obtained. I used the preferred reporting 
item for systematic reviews and meta-analysis (PRISMA) flowchart diagram to illustrate 
the procedure to select the articles (McInnes et al., 2018). The evidence that I obtained 
during the search of the literature was categorized based on the strength of evidence of 
the study.  I further analyzed the evidence obtained based on the strongest level of 
evidence to answer the practice-focused question and explain why the use of CHG 
Tegaderm™ is superior in the prevention of CLABSI compared to the existing traditional 
Biopatch® dressing. The evidence helped to answer the clinical question and fill the gap 
11 
 
in the practice of controlling the high incidence rates of central line infections and 
provide a clear evidenced-based practice of using the adhesive CHG gel Tegaderm™ in 
the reduction of CLABSIs based on supporting evidence from the literature. 
Significance 
Stakeholders 
The stakeholders that will be affected by addressing the aforementioned problem 
include but not limited to the patients, nurses, physicians, midlevel providers, infection 
control practitioner, hospital administrators. External stakeholders such as the CDC, 
government agencies and payers, health care organizations among others will be affected 
by the reduction of CLABSIs. Understanding the role and contribution of each 
stakeholder is an important part. To ensure full support of a project that involves different 
stakeholder, it essential to involve a multidisciplinary team when introducing new 
practice. For instance, CLABSIs being a nonrefundable event by Medicare, it is essential 
to involve the administration or management to have a buy-in in the change of practice if 
the rates of CLABSIs are going to be decreased or brought to zero cases. The physicians 
and the advanced practitioners are the ones who insert the central line. Therefore, 
involving them and teaching how the change of the current practice will impact their 
work and have the competence or knowledge of the new dressing when inserting the 
central line will increase the buy-in and ensure support of the new practice. Nurses are 
the one who change the dressing after it is inserted. Teaching them and providing facts 
and evidence-based prove that the dressing is superior and easy to use is important. All 
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stakeholders who will impact the new change should be involved directly to ensure the 
success of the new practice. 
Contribution of the Doctoral Project to Nursing Practice 
Doctoral prepared nurses contribute to the growth and improvement of patients’ 
care by designing, implementing, and evaluating therapeutic interventions based on 
nursing science as is evidenced by the essentials of doctoral education for advanced 
nursing practice Essential III: Clinical Scholarship and Analytical Methods for Evidence-
Based Practice and Essential VIII: Advanced Nursing Practice (American Association of 
Colleges of Nursing, 2006). With the increased need to improve patients’ care, improve 
patients’ safety and quality of life, the use of evidence-based practice continues to be the 
focus of providing patients’ care in nursing practice. Conducting a systematic review of 
the use of CHG dressing to reduce the CLABSI rate yielded the highest evidence of why 
the intervention is superior compared to the general standard central line dressing. The 
project promoted the need for more application of evidence-based practices in the 
provision of care in nursing. The review provided a clear answer to why the dressing 
should be a priority if the cases of CLABSIs will be reduced or brought to zero. The 
project added knowledge to the healthcare providers and other stakeholders of why to 
advocate for practices that have been proved to be of high quality to increase patient 
safety (Connor, Paul, McCabe, & Ziniel, 2017).  
Health care decisions making should be guided by the best available research 
evidence. By practicing using the best evidence-based medicine, the health care providers 
integrate their clinical expertise with the best available external clinical evidence from the 
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systematic literature review and patient’s values and expectations. In this sense, the 
external clinical evidence was retrieved from the available literature, and the evidence 
was synthesized to answer the clinical question. The use of available evidence extracted 
from exploiting the medical research on how a particular intervention has been practiced 
obtaining an intended outcome and synthesize that information as a raw data are in a 
typical experiment and is essential when conducting a systematic review. The advantage 
of a systematic review in guiding the implementation of a particular intervention is that it 
provides the health care providers or facility with an easy to read summarized findings of 
all relevant individual studies over a health-related issue. The systematic review aims to 
identify, evaluate, and synthesize the results of all relevant individual studies and make 
the evidence available and easily accessible to decision-makers who may not have 
enough time to look at different articles while making decisions in their patients’ care 
(Gopalakrishnan & Ganeshkumar, 2013). 
Transferability to Similar Practices 
Better patients care involves the integration of evidence-based practice that is 
obtained through research and the clinician expertise combined with best patient values to 
produce positive patients’ outcome. The use of evidence-based practice has been 
effectively emphasized as the most and effective method for clinical decision making to 
improve patients’ health and reduce health care cost. The evidence-based practice of 
reducing the CLABSIs can be used in other critical cares units or hospitalized patients 
with the central venous catheter. The results of this systematic review can be shared with 
other similar critical care units within the health care system, or in other patients with the 
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central venous catheter in the local city, state or at the national level. With the increasing 
need to have evidence-based practice in health care, having medical evidence based on 
credible literature and forms as a basis of clinical and policies decisions making is 
important. Those who contribute to the synthesis of evidence as in the case of systematic 
review should ensure that the information is accurate and unbiased. The systematic 
review is a form of research and therefore maintaining the integrity of evidence retrieval 
is an important ethical issue that should be considered. Bearing in mind that the evidence 
synthesized will be used to implement interventions that are meant to improve human 
care, the evidence obtained should be of high quality and the reviewer should be 
transparent in the systematic review process in a manner that can be reproducible, and 
results can be applied in other settings other than the local facility with the clinical 
problem. Any potential conflicts of interest should be declared to ensure that the reviewer 
was not influenced by certain individuals or companies to make recommendations based 
on the available published literature. All the information that was used to guide the 
systematic review was obtained from published literature, and there is no conflict of 
interest when conducting the systematic review to recommend the use of adhesive 
transparent CHG Tegaderm™ gel dressing (Wager & Wiffen, 2011). 
Implications for Positive Social Change 
Reducing the rate of unwanted and preventable deadly infections preserve life and 
save billion dollars that are spent to treat infections such as CLABSI. Having an 
intervention that is aimed in the prevention of CLABSI and is evidence-based supported 
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with the highest level of evidence will be applicable and contribute in filling the gap that 
exists to prevent CLABSI hence will add to positive change. 
Summary 
In section 1, I provided background information for the systematic review project. 
I outlined the project question, the use of the study, the nature of the study, and the 
importance of decreasing the CLASBIs. I explored the highest level of evidence to justify 
why the use of adhesive transparent chlorohexidine gluconate Tegaderm™ is superior in 
reducing the CLASBIs compared with the standard Biopatch® dressing. In the next 
section, I will explore the supporting framework and the background information to 
support the project. 
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Section 2: Background and Context 
Introduction  
The use of evidence-based practice is the best guide and framework of nursing 
practice to improve the patients care for optimum patients’ outcome. The use of 
evidence-based is the new innovative approach in addressing the complex and needed 
daily needs of the patients served (McEwen & Wills, 2014). The focused practice 
question in my study was: “Does the use of adhesive transparent chlorohexidine 
gluconate Tegaderm™ for adults above 18 years of age admitted to acute and critical care 
unit with the central venous catheter decrease the CLABSIs rate?” My aim in this 
doctoral project was to search, retrieve, analyze, synthesize and summarize the best 
evidence-based practice in the reduction of CLABSI in acute and critical care units. 
 CLABSIs infections are common in hospital settings, especially in acutely ill 
patients. CLABSIs are among the deadliest HAIs that occur daily and are considered as 
noncompensated incidences by Medicare and Medicaid. Chlorohexidine gluconate 
Tegaderm™ gel central line dressing has been shown to reduce the rate of CLABSIs in 
adult in critical care units, but it remains unused despite the supporting evidence. 
Therefore, in this section, I will discuss the practice-focused question and the use of the 
theoretical framework/model to guide the systematic review. I will also discuss the 
relevance of the project to nursing practice, the background information of the project, 
and my role as the Doctor of Nursing practice (DNP) student in the project. 
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Concepts, Models, and Theories 
Theoretical Framework 
 The need to have evidence-based practice in the health care is to guide the health 
care professionals based on the latest evidence and scientific development based on 
research. The evidence-based in this project was the use of adhesive transparent 
chlorohexidine gluconate gel Tegaderm™ dressing to decrease the CLASBI rate. The 
practice-based evidence enables the clinicians or health care professionals to generate 
knowledge from practice and research. The practice-based concept enables the clinicians 
to integrate clinical experience and research evidence to make a sound clinical judgment 
when caring for patients with a central venous catheter to reduce the CLABSIs (McEwen 
et al., 2014). 
Reducing the rate of health care-acquired infection is an essential aspect of 
nursing practice. Reducing HAI does not only avoid the health care burden but also 
reduce the mortality and morbidity of the patients. In this project, the logic model served 
as a theoretical framework toward the systematic review of how CHG Tegaderm™ gel 
central line dressing can reduce the rate of CLABSIs compared with the standard 
Biopatch® dressings. Logic model is also known as a roadmap, theory of change, or 
model of change, is a graphic depiction that represents the activities and the intended 
outcomes of the program (see Figure 1 in Appendix D). The use of logic model helped to 
articulate the current situation of CLABSIs and how a different intervention that is not 
currently being practiced can contribute to the reduction of CLABSIs (CDC, n.d.). The 
use of the logic model helped to provide a visual approach for the project by aiding in 
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identifying the flow of the project, the goals, resources or inputs to meet the goals of the 
project, the output needed to complete the goals, the project outcomes and the effects of 
the project (Kettner, Moroney, & Martin, 2017). 
The advantages of using logic models in the systematic review of the literature are 
because they aid in helping the reviewer to think critically during the review process. It 
also assists in identifying the inclusion and exclusion criteria, and guide how to research 
the literature. Logic models aid in defining the outcomes of the review, identifying the 
mediating and moderating factors, and disseminate the findings once the study 
completed. The use of logic models in this systematic review of literature helped to 
articulate how the intervention of CHG Tegaderm™ dressing can help decrease the rate 
of CLABSI in the acutely ill patients. The model helped to explain how intervention 
affects a change (Kneale, Thomas, & Harris, 2015). 
Concepts/Terms Used in Doctoral Project 
1. Tegaderm™: A transparent medical dressing that is used to cover and protect 
wounds or catheter sites (Madhav, Matthew, & Edward, 2018). 
2. Biopatch®: A protective Disk with CHG dressing for reducing infections and 
skin colonization of microorganisms (Nicholls, 2014). 
3. Central venous catheter: An intravascular venous catheter that is placed at or 
close to the right side of the heart. The catheter is used in infusing medicine or 
blood, drawing blood, administering medications and antibiotics, 
administering fluids, and for hemodynamic monitoring (Bonne, Mazuski, & 
Schuerer, 2015). 
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4. Health care-associated infection (HAI): An infection that develops when a 
patient has cared in health care settings such as the hospital, outpatient clinic. 
The disease is associated with the care being delivered by a health care 
provider (Bonne et al., 2015). 
5. CLABSI: A primary bloodstream infection that is associated by the presence 
of a central line or umbilical catheter within 48 hours before, onset of the 
infection, with no other source of infection evidence other than the catheter. 
The infection can happen any time regardless of the time the catheter is in 
place (Bonne et al., 2015). 
Relevance to Nursing Practice 
History of the Problem in Nursing Practice 
The use of evidence-based practice to solve the problem is critical in the decision 
making in the health care and nursing practice. Many interventions in the care of the 
patients are now correlated with the recent evidence-based practice that has been proven 
to be effective. With the increase in the demand for better quality care in the provision of 
care, an increasing need exists for using evidence-based practice in the nursing field in 
the health care decision making. There is an increased need to use interventions based on 
the evidence-based practice. Many organizations that support high-quality patients’ care 
and high level of nursing care such as the Magnet Recognition Program of the American 
Nurses Credentialing Center are dwelling on the use of evidence-based practice to be 
applied in the daily nursing practice. The Institute of Medicine recommends the use of 
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evidence-based practice to be integrated into the care of the patients or nursing practice 
by the year 2020 (Institute of Medicine. 2010).  
Nurses play a crucial role in the prevention of infections especially nosocomial 
infections such as the CLABSIs. CVC have become indispensable in health care today 
because of their critical use in the management of patients’ health such as the patients 
who are critically ill. CVCs help in hemodynamically monitoring of acutely ill patients, 
medication administration and delivering parenteral nutrition. When they are inserted, 
they break the skin integrity as the first line of defense for fighting infection among 
others. Thus, patients are exposed to the most frequent cause of nosocomial infections 
known as CLABSI. CLABSI is considered a National Patient Safety Goal by the Joint 
Commission of Healthcare Organization (“Hospital National Patient Safety Goals”, 
2017). Nurses as the frontline providers of care to their needy patients make a significant 
impact in reducing CLABSI and thus improves quality and safety of the patients’ care 
and affect the financial stability of the health care organization. 
The patients’ safety challenges to reduce the number of preventable CLABSI that 
occur 4 days beyond the insertion of the central line are detrimental to the patients’ lives 
and add hefty cost to the facility and the health care. When the facility spends money on 
unnecessary incurrence that could be prevented, it impacts the budget assigned to the 
unit, and this affects the nursing unit directly and indirectly. I remember working as a 
bedside staff nurse, and sometimes we were told that our budget was tight because our 
staffing, expenses are over the budget allocated to the unit. Cutting unit budget can affect 
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the nurses’ morale, lack of equipment’s to work with, and this will lead to poor service 
delivery. 
Current Nursing Practice for Central Venous Catheter 
Many facilities follow the central venous catheter bundles that incorporate 
evidence-based science into practice in the care of CVC. The bundles have guidelines 
that should be followed and the application of Biopatch® with standard central line 
dressing during CVC insertion and dressing changes. Despite these bundles and proper 
adherence, CLABSI incidences are still high. Having an intervention that can reduce the 
CLABSIs to almost zero is a significant intervention that can be applied to the hospital 
and contribute positively to the nursing practice. As caring professionals, nurses have 
always saddened if the patients die because of an infection that could have been 
prevented. The use of CHG Tegaderm™ has been proven to be useful in the prevention 
of CLABSIs. Therefore, the project will contribute positively to the nursing practice. 
Previous Strategies 
Despite the CDC and the Healthcare Infection Control Practices Advisory 
Committee (HICPAC) guidelines on caring for the central venous catheter, the rate of 
intravascular catheter-related infection such as CLABSI is still rampant. Many hospitals 
abide by the CDC and HICPAC’s central lines guidelines and performance improvement 
strategies by implementing the central line bundle strategies as outlined by the CDC, but 
the rates of CLABSI are still high. Therefore, the review of the literature provided 
enough evidence to support the use of chlorohexidine gluconate Tegaderm™ gel. 
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How the Doctoral Project Advances Nursing Practice 
CLABSIs are detrimental to the life of the already acutely ill patients whose their 
immune system is very fragile. Being a nosocomial infection, the issue of how a unit or a 
hospital can be able to prevent CLABSI completely to zero in 1000 days remains a 
challenge. The current bundles are applied to almost every hospital and emphasized each 
day on how to prevent this deadly disease. Despite these measures, CLABSIs are still 
rampant and contribute to mortality and morbidity of many citizens and contribute to a 
huge financial burden on the already burdened health care system. Therefore, conducting 
the systematic review on an evidenced-based practice that can be applied to reduce the 
cases of CLABSI filled the gap that already exists in the nursing practice on the best 
method or effective method to reduce CLABSI cases. The doctoral project shed light with 
an intervention that is evidenced-based backed with the highest evidence from the 
literature. 
Local Background and Context 
Local Evidence on the Relevant of the Practice Problem 
Decreasing CLABSIs is essential for nursing practice especially with a facility 
that is aiming for Magnet designation and to decrease the mortality and morbidity 
associated with CLABSI. Money that spent on treating CLABSI can be used to buy state 
of the art equipment that facilitates a favorable environment for nursing staff. 
Tegaderm™ CHG is easier to use and reduces the rate of infection and the evidence I 
obtained proved that the dressing is preferred in the clinical settings by the end users. The 
local facility is targeting to transition from the standard CVC dressing to the Tegaderm™ 
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CHG gel if there is enough evidence to convince hospital leadership that the latter is 
better than the regular dressing. Also, the goal of the local critical care unit is to have less 
than five CLABSIs per 1000 central line days. Due to the increase in the number of 
CLABSIs in spite of the local critical care unit adherence to the CDC central venous 
catheter bundle guidelines, there is need to find solutions that can help improve the care 
of the CVCs in the hospitals.  I formulated a practice-focused question to find the best 
evidence to back the recommendations of the use of an adhesive transparent 
chlorohexidine gluconate Tegaderm™ gel dressing on how it is superior to decrease the 
rate of CLABSIs. Therefore, my doctoral project involved conducting a systematic 
review of the literature to answer the practice-focused question of “Does the use of 
adhesive transparent chlorohexidine gluconate Tegaderm™ for adults above 18 years of 
age admitted to acute and critical care unit with the central venous catheter decreases the 
CLABSIs rate?”  
Institutional Context on the Relevant of the Practice Problem 
The practicum site I carried the project is a critical care unit in a local acute care 
hospital in Dallas, Texas. The critical care unit has 64 beds in a hospital of more than 500 
inpatient beds. The practice question was developed as a request by the critical care team 
leadership request to conduct a systematic review of the literature to find the available 
evidence that supports the impacts of CHG Tegaderm™ central line dressing compared 
to the traditional Biopatch® dressing. The local critical care unit has current CLABSI 
rate of 0.962 and the whole hospital has a CLABSI rate of 1.232 for the current fiscal 
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year starting October 1st, 2017 to September 30th, 2018. The critical care leadership in the 
local hospital had identified the need: 
1. To decrease the numbers of CLABSIs per 1000 central line days.  
2. To achieve the target goal 0.641 per fiscal year. 
 Nurses who work in the unit and have part-time jobs in other hospitals have 
explained how one of the hospitals in Dallas, Texas has implemented the use of CHG 
Tegaderm™ gel dressings and within 1000 hospital days, the unit had a lower rate of 
CLABSIs per 1000 central venous catheter days for a critical care unit with 50 beds. To 
convince the management to change the central line dressing from the standard 
Biopatch® dressing, the critical care unit needed enough evidence and investigation to 
prove that the CHG gel Tegaderm™ dressing is superior in reducing the CLABSIs. 
Therefore, I formulated the above practice question to investigate and reviewed literature 
for the evidence of how CHG Tegaderm™ is excellent in the reduction of the CLABSIs. 
State and Federal Context of the Problem 
CLABSIs are reportable health care-associated infections (HAIs) in both the state 
and the national level. The Texas Department of Health and Human Services requires 
health care facilities to report HAI through a reporting database called the National 
Healthcare Safety Network (NHSN), maintained by the Division of Healthcare Quality 
Promotion (DHQP) at the CDC.  The standardized infection ratio (SIR) is a new method 
that is being used in summarizing HAI experiences across any number of health care 
facilities or any types. The advantage of SIR is that it can assess HAIs at a national, state, 
or local level. For adults in ICU, the CLABSI risk adjustment uses patients’ care location, 
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bed size of the patients’ care location and hospital affiliation with a medical school to 
determine the risk of acquiring an infection (Malapiedi, 2013). To calculate CLABSI-
SIR, the total number of observed CLABSI events is divided by the predicted number of 
CLABSI events based on the national CLABSI rates. The predicted number of CLABSI 
events is calculated by multiplying the national CLABSI rate by the number of central 
line days that occurred in the hospital unit and divide by 1000. The CLABSI rate is per 
1000 central line days. For instance, if the number of national CLABSI rate is five, and 
the number of CLABSI in the above facility is 10 in 1000 days, then the predicted 
number of CLABSI for this unit is, 
(Observed central line days) * (National rate) = (1000) * (5.0) = 5.0 
        1000              1000 
5.0 is the number of expected/predicted CLABSIs for this location at this hospital. 
Therefore, to calculate the SIR 
SIR =  (Observed # CLABSIs) =    10    = 2.0 
 (Predicted # CLABSIs)       5 
If the SIR is greater than 1, it means that the health care facility has more HAI 
than the national baseline, meaning it is doing worse than the national experience and 
vice versa (Malapiedi, 2013). 
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Role of the DNP Student 
Student Professional Context 
I am currently practicing as an adult-gerontology acute care nurse practitioner at a 
correctional facility in a large city in Texas. Although my current role doesn’t involve 
patients with central venous catheter, my previous nursing background was in critical 
care unit where I helped clinicians’ insert central venous catheter and I directly was 
involved in assessing and changing the central venous catheter dressing. My practicum 
site was my former work place and therefore, I have experienced patients developing 
CLABSIs during my direct bedside nursing career at the practicum site. As a former 
critical care nurse, I have observed patients developing CLABSIs due to the infected 
central line catheter.  
Role of the Student in the Doctoral Project 
The American Association of Colleges of Nursing describes eight essentials that a 
doctoral-prepared nurse attains upon graduation from a doctoral program. The Clinical 
Scholarship and Analytical Methods for Evidence-Based Practice (Essential III) is one of 
the essential that I have applied in this doctoral project. Turning original research to 
evidence-based practice and use the evidence to solve the clinical problem is a significant 
hallmark of doctoral education (American Association of Colleges of Nursing, 2006). 
Doctoral prepared nurses should take the lead to foster changes at the organization level 
national level, nursing practice, and health care at large. With the skills, knowledge, and 
experience I have learned during the doctoral program, I have applied them while I 
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conducted a comprehensive systematic review of the literature to find answers to the 
question raised above. My role in this project was the primary sole researcher and 
evaluator of the highest level of evidence, identified the evidence attained, appraised the 
evidence for inclusion in the review and determined the quality of the evidence retrieved. 
I also synthesized the evidence obtained making easy to read and comprehend and more 
natural to be applied into practice to solve the clinical problem. 
Motivation for the Doctoral Project 
Throughout the doctoral program, the use of evidence-based practice has been 
emphasized in almost every class I have taken during my doctoral studies. As a doctoral 
prepared nurse, it is essential to always aspire to improve the knowledge and lead in the 
adoption of the evidence-based practice in our nursing practice as leaders and scholars. 
As an advanced nurse practitioner, it is my aspiration to improve the care of the patients 
and be a mentor to the novice nurses in the improvement of patients’ care and how 
nursing is practiced. I am determined to find the best evidence that will support the 
clinical question in my endeavor as a scholar and practitioner. As a former critical care 
nurse, I have observed patients developing CLABSI due to the infected central line 
catheter. I have assisted clinician insert a central line and have changed the central line 
dressing multiple times. The Biopatch® used with the standard central line dressing is 
supposed to prevent central line infection, but because the material is opaque, it is hard to 
assess the site of the insertion. Failure to use it in the standard dressings leaves the site 
with no antibacterial coverage. Some facility such as a one unit I worked at had opted not 
to use the Biopatch® so the clinicians can have easy access to the insertion site. This is 
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not the best practice, because it leaves the site open for microbial organisms that are 
microscopic to view with bare eyes. The advantage of Chlorohexidine Tegaderm™ gel 
dressing is that it will enable the health care providers to assess the site at the same time 
having antimicrobial activity that helps protect the central line and the patients. To 
achieve zero or decreased numbers of CLABSI in 1000 central line days is at the heart of 
every nurse and the health care facilities and this is why finding the highest level of 
evidence to support this evidence-based practice is paramount.  
Potential Biases 
Biases can arise during a study and can be introduced at any point during a study. 
Sticking to the highest level of evidence and avoiding any opinions from stakeholders or 
non-expert ensured yielding better results in the systematic review of the literature. Also, 
ensuring that the systematic review is supported by the highest level of evidence such as 
meta-analysis and systematic review of randomized clinical trials randomized critical 
trails studies and non-randomized clinical trials ensured minimal bias of the studies. 
Ensuring that the process was transparent and indicating the process of retrieving and 
arriving at the selected articles to form the evidence to answer the clinical question 
ensured the process was clear and it is reproducible (Melnyk, & Fineout-Overholt, 2011). 
Role of the DNP Project Team 
The project team for this doctoral project is the critical care nursing leadership, 
practicum mentor, and the critical care unit-based council. After completion of the 
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doctoral project, I will present the findings to the critical care team. I solely conducted 
the systematic review of literature.  
Summary 
Section 2, I provided the theoretical framework that guided the project and I 
discussed the local background of the project and why I conducted it. I also identified the 
impact of the study in the nursing practice and the role I played in the development of the 
project. In the next section, I will reframe the question of the study and provide the 
literature support and the synthesis of the evidence. 
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Section 3: Collection and Analysis of Evidence 
Introduction  
The Problem and the Purpose 
Central venous catheters are essential in the critical care unit because of the 
ability to administer fluids, blood, antibiotics, parenteral nutrition, and hemodynamic 
measurement. Due to their proximity to the heart, the chance of causing infection is very 
high. Biopatch® dressing has been widely used in many years as part of the central line 
management bundle, but the infection rate continues to rise or never been eliminated 
regardless of how thorough and sterile the insertion and dressing change of the central 
line is. The use of transparent Tegaderm™ with CHG is new and has been proved to be 
more superior to the traditional standard Biopatch® dressing. Due to the cost of treating 
CLABSI, which is considered as a hospital-acquired infection (HAI) and the morbidity 
and mortality associated with CLABSI, finding a solution on how to decrease the rate of 
CLABSIs or prevent them is crucial not only to the local health care facility but the 
nursing practice at large. The systematic review of the literature enabled retrieval of the 
highest evidence to support the use of adhesive transparent chlorohexidine gluconate 
Tegaderm™ for adults above 18 years of age admitted to critical care unit with a central 
venous catheter to prevent CLASBIs. My purpose in this doctoral project was to conduct 
a systematic review of the literature to find the highest level of evidence to fill the gap 
that still exists in preventing CLABSIs in acute and critical care settings. In section 3, the 
focus will be on the practice-focused question, source of evidence, systematic review 
methodology, and the analysis of evidence (Jenks et al., 2016).  
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Practice-Focused Question 
The Local Problem, Gap in Practice and Focused Question 
Central venous catheters are widely used in intensive care units to administer 
drugs or fluids. The use of Biopatch® with central line dressing has been widely used for 
years, but the CLABSIs rates are still high. Recently, there is a new intervention that is 
using Tegaderm™ with CHG gel, which is transparent, and adhesively secures the central 
line site and allows the clinicians to view the site. The water-vapor-permeable CHG-
impregnated gel pad is incorporated onto the adhesive side of a transparent polyurethane 
dressing, and the CHG-impregnated gel pad is applied directly over the insertion site at 
the time of catheter insertion or during follow up site care. The gel rapidly softens at skin 
temperatures and flows about the catheter, providing intimate contact of the CHG-
impregnated surface with the entire insertion site. The gel also absorbs up to eight times 
its weight in fluid, preventing accumulation of moisture on the site. The integrated 
dressing tightly secures the catheter, preventing any positioning movement that can 
facilitate entry of microorganism into the insertion tract (Maki et al., 2008). The dressing 
acts as a barrier against external contamination, and the gel pad has an antiseptic agent. 
The use of CHG-impregnated dressing placed during the time of CVC insertion and 
dressing changes ensures the dressing to release the chlorhexidine onto the skin for a 10-
day period. The reduction of CLABSI is an area that many hospitals are still struggling to 
control.  
The local hospital is still struggling with CLABSIs with most time doing worse 
than the national average despite application of the central line bundles guidelines in the 
32 
 
care of the central venous catheter. The critical care leadership team anticipates a 
decrease in the rate of CLABSIs with the introduction of CHG Tegaderm™ gel instead of 
the traditional Biopatch® dressing if approved by the administration and after having 
clear strong supporting evidence. With the increasing need to provide the highest quality 
and minimize the rate of central line infections, the gap in nursing on the reduction of 
CLABSIs still exists on the best highest quality method that can be used to decrease or 
have zero chances of CLABSIs. The purpose of this systematic review of the literature 
was to evaluate why the use of transparent IV dressing with CHG gel is essential to 
reduce the infection compared to the standard CVC dressing with Biopatch® during the 
insertion and dressing changes. The result of the systematic review will be crucial to the 
facility and the nursing practice to contribute to how the deadly disease can be prevented. 
The systematic review of the literature allowed gathering evidence from different 
sources. The evidence was broken down from the highest level to the lowest level to 
answer the practice-focused question and only the level 1-3 according to the Melynk and 
Overholt’s hierarchy of evidence (2011) were included in the review to minimize any risk 
of bias in the studies.  
The practice question that guided this systematic review of literature is: Does the 
use of adhesive transparent chlorohexidine gluconate Tegaderm™ for adults above 18 
years of age admitted to acute and critical care unit with the central venous catheter 
decrease the CLABSIs rate? 
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Clarifying the Purpose 
My aim of conducting this doctoral project was to evaluate and synthesize the 
available evidence-based research on the use of adhesive transparent chlorohexidine 
gluconate Tegaderm™ and find why it is superior in the reduction of CLABSIs compared 
to the traditional Biopatch® dressing. The approach to collect the evidence was guided 
by the practice-focused question of “does the use of adhesive transparent chlorohexidine 
gluconate Tegaderm™ for adults above 18 years of age admitted to critical care unit with 
the central venous catheter decrease the CLABSI rates?” My aim was to gather data with 
the strongest highest level of evidence to answer the practice-focused question and 
support the use of adhesive transparent chlorohexidine gluconate Tegaderm™ as an 
intervention that will be implemented in the clinical setting to solve the problem of 
CLABSIs. 
Sources of Evidence 
The motive of conducting this project was to find, retrieve, evaluate, and 
synthesize the best available published literature as evidence relevant to the new CHG 
gluconate gel integrated transparent Tegaderm™ in the care central venous catheter that 
is determined to be superior to the CHG Biopatch®. Due to the nature of the project, only 
the published literature was used to answer the practiced focused question as the source 
of data and evidence. The systematic review was guided by the practice-focused question 
of, “does the use of adhesive transparent chlorohexidine gluconate Tegaderm™ for adults 
above 18 years of age admitted to critical care unit with the central venous catheter 
decrease the CLABSIs rate?” The aim of conducting this literature review was to 
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evaluate and synthesize the best available evidence that was relevant to the use of 
adhesive transparent chlorohexidine gluconate Tegaderm™ in the prevention of the 
CLABSI rate. The source of evidence that I used to address and answer the practiced 
focused-question came from the primary and secondary sources of peer-reviewed journal 
articles from the databases mentioned below and the google scholar. I conducted a 
comprehensive literature review using online databases and the Google scholar. The 
following databases were used for the search of the current literature: Cochrane Database 
of Systematic Reviews (CDSR), PUBMED, EMBASE, Cumulative Index to Nursing & 
Allied Health Literature (CINAHL) and Medical Literature Analysis and Retrieval 
System Online (MEDLINE) combined search, ProQuest Nursing and Allied Health 
Source database, and Google Scholar. The search was exhaustive and comprehensive. 
The inclusion criteria were articles published within a period of 10 years old from 2008 
to 2018 focusing on central line infections, full articles published in English, full articles, 
and focus on adults. Articles older than ten years were excluded from review, non-
English articles and articles dealing with pediatrics or younger than 18 years of age.  
Relationship of the Evidence to the Purpose of the Project 
After searching the literature, 249 articles from databases and 124 from google 
scholar were obtained and 211 articles were left after removing the duplicates. The 
abstracts and references of the remaining 211 articles were screened and 165 articles 
were excluded as they did not meet the inclusion criteria, or they were found to be 
irrelevant to the study. Twenty-seven full articles were selected and 16 met the inclusion 
criteria for the final inclusion and 11 articles were excluded with reasons given as 
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detailed in the exclusion table (see Table 3 in Appendix C). The inclusion criteria for this 
systematic review included (a) articles addressing adults older than 18 years in acute or 
critical care hospital with the central venous catheter that has CHG Tegaderm™ dressing, 
(b) full-text articles, and (c) articles published between 2008 and 2018 and in the English 
language. The evidence obtained after an extensive search of literature helped to connect 
the purpose of this doctoral project to evaluate why the use of transparent IV dressing 
with CHG gel is an evidence-based recommendation to reduce the infection compared to 
the standard CVC dressing with Biopatch® during the insertion and dressing changes. 
The comprehensive and exhaustive search process resulted in 16 full articles that met the 
inclusion criteria and were used in this systematic review. The initial search of the 
literature started in the CINHAL with MEDLINE combined with the initial word used 
was the central venous catheter. The results of the systematic review will be essential to 
the facility to help meet the core measures as a quality indicator and reduce the 
unnecessary costs to treat CLABSI infections. The review will also be significant to the 
nursing practice to contribute to how the deadly disease can be prevented. The evidence 
retrieved from the literature is strong to validate the use of adhesive transparent 
chlorohexidine gluconate Tegaderm™ in reducing CLABSIs as the best practice that is 
supported by the literature and superior to the tradition Biopatch® dressing.  
Evidence to Address the Practice-Focused Question 
The collection and analysis of the evidence helped to answer the practice-focused 
question of the doctoral project. The articles selected were those retrieved after the search 
words were used in the databases identified above and the google scholar and those that 
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met the inclusion criteria established before the collection of data from the online 
published literature. The search words used to retrieve data were: the central venous 
catheter, Tegaderm™ CHG gel, adult critical care, bloodstream infection, CHG dressing, 
and the CLABSIs, and CHG Tegaderm™ gel. After collecting the evidence and the 
articles that met the criteria were selected, Fineout-Overholts hierarchy of evidence was 
used to synthesize and critically appraise the evidence obtained to answer the practice-
focused question. The evidence table covers the type of evidence, levels of evidence, and 
the description of evidence (Melnyk & Fineout-Overholt, 2011). The collection and 
analysis of the obtained evidence helped to address the benefits and effectiveness of 
using CHG gel Tegaderm™ dressing in the central venous catheter in the reduction of 
CLASBIs.  
Research Method 
The research method was a systematic review of the literature to retrieve evidence 
from published literature from online databases and google scholar. The pre-defined 
practice focused question guided the finding of the evidence and retrieving the evidence 
based on the inclusion criteria defined by the practiced focused question. After approval 
by the university review board to collect data for the doctoral project, I used different 
databases using the Walden University Library and Google Scholar to retrieve articles 
using the search terms such as the central venous catheter, Tegaderm™ CHG, standard 
intravenous dressing, adult critical care, bloodstream infection, chlorhexidine gel 
dressing, and central-line related bloodstream infection (CLABSI). I used different 
databases such as the Cochrane Database of Systematic Reviews (CDSR), National 
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Library of Medicine (NLM), PubMed Health, Biomed Central, Cumulative Index to 
Nursing & Allied Health Literature (CINAHL), Joanna Briggs Institute EBP Database, 
ProQuest Nursing and Allied Health Source database and Google scholars to search the 
evidence. 
Published Outcomes and Research 
Databases and Search Engines 
I assessed articles to answer the practice-focused question from the following 
databases: Cochrane Database of Systematic Reviews (CDSR), PUBMED, EMBASE, 
Cumulative Index to Nursing & Allied Health Literature (CINAHL) and Medical 
Literature Analysis and Retrieval System Online (MEDLINE) combined search, 
ProQuest Nursing and Allied Health Source database, and Google Scholar. I used Walden 
University online library and search engines such as the Google Scholar to assess the 
articles that met the criteria for the practice focused question.  
Key Search Terms 
The search terms and word combinations that used included a central venous 
catheter, Tegaderm™ CHG gel, standard intravenous dressing, adult critical care, 
bloodstream infection, chlorhexidine dressing, and CHG gel Tegaderm™, and CLABSIs.  
The Scope of the Review 
My aim of conducting an extensive literature search was to find and gather 
relevant information that is related to the use of transparent IV Tegaderm™ dressing with 
CHG gel to reduce the CLABSIs. The inclusion criteria were articles published within ten 
years (between 2008-2018) and published in English language, meta-analysis articles, 
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randomized controlled trials, controlled clinical trials, and non-randomized controlled 
trials before and after studies. The demographic characteristics of the population who 
qualified for inclusion were adults above 18 years of age in acute and critical care units 
and clinicians working in acute and intensive care units. The Exclusion criteria were 
patients with already existing bloodstream infections and under the age of 18 years of 
age.  
Exhaustive and Comprehensive Search 
Searching for the literature was exhaustive as I used different databases by using 
different terms and phrase combinations that covered the practice-focused question and 
the population of patients above age 18 years. The articles that I selected were read in full 
to find which one met the inclusion criteria and exclusion criteria. I conducted an 
exhaustive search and retrieval of literature in that after removal of duplicates I read all 
abstracts and references of the articles to make sure there was no chance of missing 
important information during the search for the best highest level of evidence to answer 
the practice question.  
Institutional Review Board 
The systematic literature review does not have direct involvement of human 
subjects, and therefore, the issue of human rights did not apply in this doctoral project. 
Furthermore, after approval of the proposal oral defense by the committee chair and 
members, I contacted the Walden University institutional review board to obtain an 
authorization to conduct the systematic review of the literature to ensure that all rights 
were protected. The data of the study was from the published literature. As the study 
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project was an institutional review board pre-approved for DNP Systematic Literature 
Review, the IRB approved the implementation of the proposal with approval number 09-
12-18-0572544.  
Analysis and Synthesis 
Systems to Record, Track, Organize and Analyze the Evidence 
After retrieving the articles, those that met the criteria were reviewed thoroughly, 
evaluated and analyzed using the Melynyk and Fineout-Overholt (2011) seven levels of 
evidence (see Table 1). I manually organized and recorded the evidence obtained from 
the search of the literature in a Microsoft Word Matrix table (see Table 2 in Appendix A). 
Articles were organized into various columns by the year of publication and the name of 
the author(s), the title of the articles and the purpose of conducting the study, the research 
design used the sample size of the subjects and settings, the findings of the study or 
outcomes and the level of evidence. Each article was weighed against each level of 
evidence below and categorized accordingly. The findings of the articles are summarized 
in the finding section within each level for illustration and individual summary of the 
articles. 
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Table 1 
Levels of Evidence 
 
The preferred reporting item for systematic reviews and meta-analysis (PRISMA) 
flowchart diagram was used to illustrate the procedure to select the articles (McInnes et 
al., 2018) (see Figure 2 in Appendix D).  
Analysis Procedure 
The evidence that I obtained during the search of the literature was categorized 
based on the strength of evidence of the study. The highest or the most substantial level 
of evidence was used to propose the use of adhesive transparent chlorohexidine gluconate 
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central line dressing in the reduction of CLASBIs. The data analysis obtained was used to 
recommend the use of adhesive transparent chlorohexidine gluconate central line 
dressing. 
Summary 
The aim of conducting this systematic review project was to provide the 
recommendation that can yield significant help in addressing the gap that still exists in 
the prevention of CLABSIs. The results of conducting this systematic review shed light 
on the advantages of using the adhesive transparent chlorohexidine gluconate central line 
dressing compared to the traditional Biopatch® dressing in the prevention of CLABSI to 
improve patient care quality and reduce the mortality and morbidity associated with 
CLABSIs. The outcomes of the study will benefit the local facility and the nursing 
practice as well as improve the patients’ care outcomes in adult in both acute and critical 
care units. The adhesive transparent chlorohexidine gluconate central line dressing 
project has the potential to decrease the numbers of CLABSI in acute and critical care 
units that will improve the patient safety and clinical outcome in health care 
organizations when the recommendation is implemented. In this section I discussed the 
practice-focused question, the source of evidence, the Walden University institutional 
review board process, and the analysis and synthesis of the evidence that was obtained. In 
the next section, I will discuss the introduction of section four, the findings and 
implications of the extensive search of the literature, recommendations, strength, and 
limitations of the systematic review. 
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Section 4: Findings and Recommendations 
Introduction 
Central venous catheters are widely used in intensive care units and acute 
hospitals to administer drugs or fluids. The populations in adult intensive care units are 
critically ill and susceptible to infection. When catheters are introduced into the patients’ 
bodies, they become an easy port of bacterial entry if proper care is not taken. The CDC 
requires health care facilities to use the CDC guideline issued in 2011 for the prevention 
of CLABSI. The CDC requires the health care facilities to: 
1. Educate and train health care personnel who insert and maintain catheters. 
2.  Use maximal sterile barrier precautions during central venous catheter 
insertion. 
3. Use a > 0.5% CHG preparation with alcohol for skin antisepsis. 
4. Avoid routine replacement of central venous catheters as a strategy to prevent 
infection. 
5. Use antiseptic/antibiotic impregnated short-term central venous catheters and 
chlorhexidine-impregnated sponge dressings if the rate of infection is not 
decreasing despite adherence to other strategies (i.e., education and training, 
maximum barrier precautions, and > 0.5% chlorhexidine preparations with 
alcohol for skin antisepsis). 
6. Perform improvement by the implementation bundled strategies, and 
documenting and reporting rates of compliance with all components of the 
bundles as benchmarks for quality assurance 
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(Adapted from the Center for Disease Control and Prevention (2011). 
Evidence-based practices are essential to inform the practice and care that nurses 
provide to patients each day. The absence of the best central line dressing in caring for 
adults’ patients with the central venous catheter has led to the increase of the CLABSIs 
despite adherence to the CDC (2011) guidelines. The local hospital applies the 2011 CDC 
guidelines with an aim in preventing the CLABSI. After the central line insertion or 
during the dressing change, a chlorhexidine-impregnated sponge (Biopatch®) is applied 
at the site of insertion and covered with a sterile, transparent, semipermeable dressing per 
the 2011 CDC guidelines (CDC, 2011). There is a central venous catheter dressing called 
adhesive transparent chlorohexidine gluconate Tegaderm™ gel. The dressing is new in 
the market and has proved to be superior to the current standard dressing used (CHG 
Biopatch®/Sponge/Disk), but little is known about it. The need to have clear and robust 
evidence to propose the change of dressing for the local facility to decrease the rates of 
CLABSI prompted the decision to conduct a systematic review of the literature to find 
the evidence of why the proposed dressing is superior to the one currently being used. 
The gap in nursing practice still exists on the best method or best dressing for the central 
venous catheter to control CLABSIs. The purpose of this systematic review of the 
literature was to synthesize evidence relevant to the use of Adhesive Transparent 
Chlorohexidine Gluconate Tegaderm™ Gel Dressing to improve the control of CLABSI 
when implemented with the CDC 2011 guidelines for the central venous catheter.  
The practice-focused question that guided the DNP project was: “Does the use of 
adhesive transparent chlorohexidine gluconate Tegaderm™ for adults above 18 years of 
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age admitted to acute and critical care unit with the central venous catheter decrease the 
CLABSI rate?” Articles from databases such as CINHAL, MEDLINE, PubMed, 
EMBASE, and Google Scholar were used as evidence to support the systematic literature 
review. Only articles that met the criteria were included for the review, and those that 
didn’t meet the criteria were excluded with the reason for exclusion as is indicated in the 
table of exclusion (See Table 3 for Full Articles Excluded, in Appendix B).  
With the need to provide current evidence-based quality of care, it is imperative 
for doctoral prepared nurses to be in the front line to have projects that are guided to 
improve how care is being delivered to have an impact to the patients, health care 
providers, facility, and the nursing practice. As a doctoral student, I embarked on a 
systematic review project on the use of adhesive transparent CHG Tegaderm™ gel 
dressing for the central venous catheter that has been proved to be superior compared to 
the chlorhexidine Biopatch® in decreasing the central-line associated bloodstream 
infections. The project involved formulating a research question that guided the search 
words, the inclusion criteria, retrieval and synthesis of the findings to form the evidence 
to answer the clinical question. Health care decisions making should be guided by the 
best available research evidence. By practicing the best evidence-based medicine, the 
health care providers integrate their clinical expertise with the best available external 
clinical evidence from the systematic literature review and patient’s values and 
expectations. In this essence, the external clinical evidence was retrieved from the 
available literature, and the evidence was synthesized to answer the clinical question. The 
systematic review involves conducting an extensive published literature search, evaluate 
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the evidence, and synthesize the evidence to be used as supporting evidence to guide 
nursing practice. The advantage of a systematic review in guiding the implementation of 
an intervention that a health care provider or facility is intending to implement the 
intervention is that it provides quickly summarized findings of all relevant individual 
studies over a health-related issue. The aim of the systematic review is to identify, 
evaluate, and synthesize the results of all relevant individual studies and make the 
evidence available and easily accessible to decision-makers who may not have enough 
time to look at different articles while making decisions in their patients’ care 
(Gopalakrishnan & Ganeshkumar, 2013).  
The search terms and word combinations I used to search for evidence included 
the central venous catheter, Tegaderm™ CHG, adult critical care, bloodstream infection, 
chlorhexidine dressing, CHG gel Tegaderm™, and CLABSIs. The only data included are 
from those articles that met the criteria predefined before the search. After the appraisal 
of the articles using the Melynk and Fineout-Overholt’s (2011) guide on the hierarchy of 
evidence-based studies, I used the Microsoft Word Matrix Table to record the articles 
selected. I later organized the articles into various columns by the year of publication and 
the name of the author(s), the title of the articles and the purpose of conducting the study, 
the research design used, the sample size of the subjects and settings, the findings of the 
study or outcomes and the level of evidence (see Table 2, in Appendix A.). The purpose 
of conducting this systematic review of the literature was to search, retrieve, record and 
analyze the highest level of evidence available to answer the clinical question formulated 
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before the start of the project and make recommendations for the local facility and to the 
nursing practice. 
To comply with the Walden University IRB, approval was obtained to collect data 
with approval number 09-12-18-0572544. 
In Section 4, I will discuss the synthesis and summary of the findings. Articles 
that made through the inclusion criteria and evaluation are broken down in the level of 
evidence and summary explained. The implications of this systematic review are 
discussed, and recommendations are well defined. The strength and limitations of the 
systematic review are identified and discussed in this section.  
Findings and Implications 
The literature search resulted in 249 articles from database and 124 from google 
scholar based on the search terms. After removing duplicate, the 211 articles were left, 
and their abstracts and references were fully screened. One hundred and sixty-five 
articles were excluded as they did not meet the inclusion criteria, or they were found to 
be irrelevant to the study. Twenty-seven full articles were selected and reviewed, out of 
which 16 met the criteria for the final inclusion (See Table 2, Appendix A) and 11 
articles were excluded with the reasons given as detailed in the exclusion table (see Table 
3. Appendix B). The analysis resulted in (n= 16) articles that met the relevant review 
criteria (see Appendix A). Eleven articles were excluded with the reason for exclusion 
explained (see Table 3, Appendix B). The inclusion for this systematic review included 
(a) articles addressing adults’ older than18 years of age in acute or critical care hospital 
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with the central venous catheter that has CHG Tegaderm™ dressing, (b) full-text articles, 
(c) articles published between 2008 and 2018 and in the English language. 
The evidence obtained after an extensive search of literature helped to connect the 
purpose of this doctoral project to evaluate why the use of transparent IV dressing with 
CHG gel is an evidence-based recommendation to reduce the infection compared to the 
standard CVC dressing with Biopatch® during the insertion and dressing changes. The 
comprehensive and exhaustive search process resulted in 16 articles that met the 
inclusion criteria and are used in this systematic review. The initial search of the 
literature started in the CINHAL with MEDLINE combined with the initial word used 
was the central venous catheter. The results of the systematic review will be essential to 
the facility to help meet the core measures as a quality indicator and reduce the 
unnecessary costs to treat CLABSI infections. The review will also be significant to the 
nursing practice to contribute to how the deadly disease can be prevented. The evidence 
retrieved from the literature is strong to validate the use of adhesive transparent 
chlorohexidine gluconate Tegaderm™ in reducing CLABSIs as the best practice that is 
supported by the literature and superior to the tradition Biopatch® dressing. 
After retrieving the articles, I graded them using the Melynk and Finehout-
Overholt system of grading evidence and grouped them based on their level of evidence. 
The summary of the articles will be discussed below, and the complete literature review 
table is found in Table 2, Appendix A. 
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Level 1 of Evidence 
In the Melynk et al., (2011) hierarchy of evidence the level 1 is considered as the 
highest level of evidence and most powerful to provide the substantiate evidence with 
minimal bias. The level 1 included in this literature review is the meta-analysis of 
multiple randomized controlled trials. 
Safdar et al., (2014) conducted a meta-analysis of multiple randomized controlled 
trials to assess the efficacy of a chlorhexidine-impregnated dressing compared with 
conventional dressing for prevention of catheter colonization and Cather-related 
bloodstream infection. Only studies that were prospective randomized trials comparing a 
chlorhexidine-impregnated dressing with conventional site care were considered for 
selection. Nine randomized controlled trials met the criteria for inclusion in the meta-
analysis. The studies enrolled 6,067 patients with a total of 11,214 catheterizations. A 
total of 2,984 patients with 5,586 catheters received a chlorhexidine-impregnated 
dressing and 3083 patients with 5628 catheters received conventional site care. A total of 
361 of 5,586 catheters (6.5%) were colonized in the CHG gel group compared with 743 
of 5,628 (13.2%) in the comparator group. The study concluded that the use of 
chlorhexidine-impregnated dressing is beneficial in the prevention of catheter 
colonization and catheter-related bloodstream infection and should be used in patients 
that are at high risk for catheter-related bloodstream infection (Safdar et al., 2014). 
Maunoury and colleagues (2015) conducted a meta-analysis of a multicenter 
randomized controlled trial of 1,879 adults above 18 years admitted to 12 French ICUs in 
seven universities and four general hospitals from 31st May 2010 to 29th July 2011 who 
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required intravascular catheterization for 48 hours. A total of 4,163 catheters and 34, 339 
catheter-days were studied. The objective of the study was to conduct a cost-effectiveness 
analysis to determine the impact of the use of antimicrobial CHG-containing securement 
dressing compared to non-antimicrobial transparent dressing for the reduction of 
CLABSIs and other cost related to the CLABSIs. The analysis revealed a ratio of 1 to 5 
for the average number of CLABSIs occurred between CHG and non-CHG dressings 
groups respectively with 3 CLABSIs occurred in CHG group and 14 in the standard 
group. The difference in the numbers of CLABSIs was highly statistically significant 
(Maunoury et al., 2015). 
Level 2 of Evidence 
Level 2 is considered the second most powerful level of evidence in the hierarchy 
of evidence according to Melynk et al., (2011). This level includes well-designed, 
quantitative, randomized controlled trials. Timsit et al., (2012) conducted a multicenter 
randomized controlled trial in 1,879 subjects with 4,163 central venous catheters in adults 
above 18 years of age in patients in 12 ICUs in France that were required catheterization 
for 48 hours between May 31st, 2010 to July 29th, 2011 to determine if chlorhexidine-
impregnated Tegaderm™ and strongly adherent dressings decrease catheter colonization 
and catheter-related infections. The study is considered as the landmark study that 
evaluated and supported the use of transparent chlorhexidine impregnated gel dressing 
with high holding power and reinforced border. Patients were randomized to one of the 
three dressings: (1) a CHG dressing (Tegaderm™ CHG); (2) a highly adhesive dressing; 
and (3) a standard breather bale, hypoallergenic dressing. These multiple randomized 
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clinical trials found that the addition of 3M Tegaderm™ CHG I.V. Securement Dressing 
in institutions already following routine infection control techniques led to a reduction in 
catheter colonization and catheter-related infections. 21/941 (2.2%) patients in the control 
group were found to have Infection with 1.29 infections per 1000 Catheter days while in 
the CHG dressing group 9/938 (0.96%) of the patients had infections comprising 0.52 
infections/1000 catheter days. The study revealed that there was a 57% reduction in 
patients with infections and 60% reduction of infections per 1000 Catheter for the 
patients using the CHG gel dressing (Timsit et al., 2012).  
Pedrolo, Danski, and Vayego (2014) conducted a randomized clinical trial from 
October 2011 to May 2012 to assess the effectiveness of the chlorhexidine antimicrobial 
dressing in comparison to the gauze and tape dressing in the use of central venous 
catheter in 85 severe clinical and surgical adults in intensive care and adult semi-
intensive care units of a university hospital in south of Brazil. Forty-three patients were 
randomized in the intervention group (chlorhexidine antimicrobial dressing) and 42 in the 
control group (gauze and tape dressing). The study did not find any statistical difference 
in the reduction of primary bloodstream infections, local reactions to the dressing and 
dressing fixation between the two dressings (Pedrolo et al., 2014).  
Dolci, Margatho, Silveira, and deCampos (2017) conducted a randomized clinical 
trial to identify the frequency of change of chlorhexidine-impregnated gel dressings 
applied in central venous catheter insertions sites in critically ill patients. Fifty two 
patients above 18 years of age with the short-term central venous catheter and using 
chlorhexidine-impregnated gel dressing in a high complexity intensive care unit in a 
51 
 
teaching hospital in the state of São Paulo in Brazil were eligible for the study. Thirteen 
nurses of the ICU participated in the training and data collection. The nurses who 
participated in the study completed training and practice on application and removal of 
the dressing using a mannequin with a CVC. A sterile gauze fixed with adhesive tape as a 
dressing was used during the first 24 hours after the CVC insertion until the local 
bleeding has seized. The chlorhexidine-impregnated gel dressings followed and changed 
after seven days or as needed. Data were collected on a daily basis between April and 
December 2014. The researchers assessed the dressing and when the dressing had been 
changed and verified the reason for the change. A total of 64 catheters were analyzed 
with a total of 159 dressings used with a mean frequency of change being 3.04 days (SD 
= 1.917). A total of 95 changes occurred among the 159 utilized dressings. Among the 64 
CVCs, 25 were applied in a single dressing, without replacement of the dressing, and in 
39 catheters there was no need to apply a new dressing after removal of the last one. 
Considering the interruption of use of the catheter by the patients, 87% (83) dressings 
were unscheduled due to detachment and were from CVC in the subclavian vein, and 
13% (12) were scheduled changes. The study concluded that the frequency of dressing 
changes was less than seven days, resulting in more significant quantities of dressings per 
patient caused by the detachment of the dressings (Dolci et al., 2017).  
Karpanen et al., (2016) conducted a prospective comparative non-blinded single-
center clinical study to determine the antimicrobial efficacy of CHG (CHG) gel dressing 
used in patients with a CVC. Two hundred and seventy three adults above 18 years of age 
who required a CVC as part of their clinical management admitted to critical care unit in 
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a large university hospital with 75 critical care beds divided into four units between 
January 2013 and October 2014. One hundred and thirty seven patients were randomized 
to standard dressing (3M Tegaderm™ IV dressing containing no antimicrobial) group 
and 136 patients in chlorhexidine dressing (an adhesive, semipermeable, transparent 
polyurethane film dressing incorporating a transparent gel pad containing 2% CHG) 
group. The non-antimicrobial standard dressing study phases were divided into two study 
periods, before and after the CHG dressing phase. The standard dressing was the part of 
routine dressing for the CVC care in the hospital before the study. The first phase 
included recruiting half of the standard dressing group patients, and then the CHG 
introduced. After the CHG phase, the standard dressing was reintroduced and studied. 
The study revealed a significant reduction in the number of microorganisms recovered 
from the CHG gel pad when implemented with standard CVC site care compared to the 
standard dressing (Karpanen et al., 2016).  
Biehl and colleagues (2016) conducted an open-label, randomized, multicenter 
trial to investigate the effects of CVC dressings with CHG-containing gel pads in the 
setting of high-risk neutropenic patients. This was the first known randomized trial to 
evaluate a transparent CVC dressing with a chlorhexidine gel pad in neutropenic patients. 
The trial was done in 10 German hematological departments comparing the safety and 
efficacy of chlorhexidine-containing gel pad transparent CVC dressing with an advanced 
transparent CVC dressing without antimicrobial gel pad between February 2012 and 
September 2014. A total of 613 patients met the inclusion criteria to participate in the ten 
study sites. 307 patients were randomized to the CHG group (n= 307) and 306 patients to 
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the Control group (n= 306). The study revealed that the application of chlorhexidine 
containing catheter securement dressings reduces the incidence of definite or probable 
central line related bloodstream infections in neutropenic patients. The infections dropped 
overall from 17.3% to 10.4% (p= 0.014) and within 14 days of CVC placement from 
11.15 to 6.5% (p= 0.047) (Biehl et al., 2016).  
Olson and Heilman (2008) conducted a single-center randomized controlled trial 
to evaluate a new CHG catheter dressing, 3M Tegaderm™ CHG IV Securement Dressing 
for its practicality of use in clinical practice on central venous access devices compared to 
the non-CHG Tegaderm™ dressing. Sixty three patients between the age of 28-88 
admitted in Allina Hospitals requiring a central venous catheter with a peripherally 
inserted central catheter, intrajugular central venous catheter, subclavian venous catheter, 
or femoral venous catheter and expected to remain in place for at least three days were 
included in the study. Thirty three patients were randomized to the CHG dressing group 
and 30 in the control group. The clinicians assessed the dressing based on the catheter 
securement, satisfaction with the dressing, ability to see the insertion site, ease of 
applying a dressing and the ease of using the dressing correctly, dressing adherence, skin 
stripping, maceration, erythema, and edema. The study revealed that the new 3M 
Tegaderm™ CHG gel dressing was as easy to use as the standard of care (non-
antimicrobial transparent adhesive dressing) and offered many advantages over standard 
dressing such as antimicrobial activities, handles moderate bleeding and remains 
transparent and appear to provide greater catheter securement than the standard dressing 
and conformed well to the catheter (Olson & Heilman, 2008).  
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Eyberg and Pyrek (2008) conducted a controlled randomized prospective 
comparative pilot study to evaluate the ease of use and easier of training of application 
between a transparent CHG dressing versus a CHG disk (Biopatch®) in healthy 
volunteers. Twelve healthy intravascular therapy health care professionals above age 18 
years specializing in vascular access and infusion therapy with experience in applying 
and changing IV dressings in their practice were involved in the evaluation. The 
clinicians had not used the CHG gel before but had used the CHG disk in their practice. 
Dressings were applied randomly to the subjects’ locations in the right and the left side of 
the neck and left and right arms and the subjects were asked to remove them. A total of 
24 CHG gel dressing and 24 CHG gel disks were applied. The study concluded that the 
CHG gel dressing was significantly better in overall performance (p<0.0001) compared 
to the CHG disk. All the 12 clinicians rated the CHG gel dressing better or much better, 
easier to apply, ease of removing, ability to see the IV site, ease of training another 
clinician to use, and more intuitive to use compared to the CHG disk (Eyberg & Pyrek, 
2008).  
Bashir, Olson, and Waters (2012) conducted a randomized controlled trial to 
compare the performance of the antimicrobial polyurethane film dressing to two CHG-
containing insertion site dressings concerning the abilities of the CHG-containing 
dressings to suppress bacterial regrowth over a seven days’ time frame in the healthy 
adult. Thirty-two healthy male and female above 18 years of age with no dermatological 
conditions participated in the study. At the beginning of the study, four baselines samples 
of normal flora were collected from each subject. Two samples on the upper back and 
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two on the lower back. The subjects’ skin was prepped with a 2% CHG/70% isopropyl 
alcohol antiseptic. The three dressings (Tegaderm™ transparent films dressing, CHG gel 
and CHG disk) were placed on the prepped skin in a randomized design. Samples of 
bacteria were collected using the cup scrub method. The skin under the dressings was 
sampled by quadrant on days 1, 4, and 7. The suppression of the regrowth of bacteria was 
compared using an adjusted paired t-test. The study revealed that skin flora was not 
wholly eradicated during antisepsis, and regrowth occurred post antisepsis. The use of 
CHG gel dressings helped sustain a reduced bacterial count on the skin, and the 
continuously releasing CHG gel maintained suppression to a greater extent that the CHG 
disk at seven days (P = .01) (Bashir et al., 2012).  
Maki et al. (2008) conducted a prospective comparative randomized controlled 
trial to compare two novel CHG-impregnated dressings (CHG Tegaderm™ gel and 
sponge) in healthy volunteers to assess the immediate and long-term surface cutaneous 
antimicrobial activity of the two CHG (Tegaderm™ CHG gel and Biopatch®) dressings 
and a control non-medicated transparent dressing in healthy subjects. 48 healthy adults 
aged between 25 to 70 years without primary skin disorder or known allergy to CHG 
participated in the regrowth study on prepped subclavian sites at a Hilltop Research in 
Miami Ville in Ohio and 29 subjects participated in the trial assessing killing of normal 
flora on unprepped skin in research conducted in the Medical Division Laboratory of 3M 
Company in St. Paul Minnesota. The study was conducted by evaluating the 
antimicrobial activity of the two CHG dressing against normal cutaneous microflora on 
the back of the subjects by measuring the flora counts under the dressings after 1,2,4,7 
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and 10 days on sites that were not prepped with an antiseptic at the outset. Each of the 
two test areas, one on the right and other on the left were randomly sampled for sample 
counts on day zero. The 2 CHG dressings were randomly applied to the two remaining 
sites. By random assignment, one of each test CHG dressings was removed from each 
side on study days 1, 2, 4, 7, and 10 and quantitative skin cultures were obtained. The 
study concluded that the newly integrated CHG gel dressing showed powerful 
bactericidal activity against diverse nosocomial species, and both CHG dressings studied 
showed excellent immediate and especially, long-term cutaneous floral suppression and 
were tolerated. The new integrated transparent CHG impregnated gel dressing is easier to 
apply and less vulnerable to improper application, reliably secures the catheter, permits 
continuous inspection of the insertion site, and obviates the need for every-other-day site 
care (Maki et al., 2008).  
Rupp et al., (2008) conducted a prospective, randomized controlled single-center 
clinical trial in a 689 bed at Nebraska Medical Center, a University-associated, tertiary 
care center to assess the clinical performance of an innovative CHG Tegaderm™ 
dressing containing CHG gel pad in minimizing the growth of microbes at the catheter 
insertion site. 60 adults’ patients with the central venous catheter that was likely to 
remain in place at least three days participated in the study. Tegaderm™ CHG containing 
gel dressing and the transparent, semipermeable polyurethane dressings were randomly 
assigned to the insertion site. Dressings were evaluated daily for adherence, catheter 
securement, transparency, and skin condition, the presence of moisture or blood, and 
patient comfort. At day seven, the microbiologic assessment was done for subjects with 
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catheters seven days of continuous study dressing wear by collecting a swab culture at the 
catheter insertion site. The study revealed that the Tegaderm™ CHG dressing containing 
a chlorhexidine gel pad is an innovate means to minimize catheter-associated 
bloodstream infection potentially. The Tegaderm™ CHG dressing is well-tolerated and 
judged to be superior to the comparator dressing with regard to catheter securement and 
overall satisfaction (Rupp et al., 2008).  
Level 3 of Evidence 
Level 3 in the hierarchy of evidence is the evidence obtained from well-designed 
controlled trials without randomization (Melynk et al., 2011). Zehrer, Smith, and 
Deschneau (2010) conducted a multicenter clinical trial to compare the performance of a 
new transparent CHG gel pad dressing versus a CHG disk (plus transparent dressing). A 
total of 321 clinicians from 16 US hospitals were enrolled to evaluate the application of 
500 new CHG gel pad dressings. The 16 hospitals were using the CHG disk (Biopatch®) 
before the clinical evaluation. During the time of the study, the nurses only applied the 
new CHG gel dressing and completed a written questionnaire after the study to compare 
the two products. 80.6% (95% lower CI: 76.2%) of evaluators recommended replacing 
their current product with the transparent CHG gel pad dressing (p=0.0178) (Zehrer et al., 
2010).  
Pfaff, Heithaus, and Emanuelsen (2012) conducted a quality improvement 
observation study in an adult medical-surgical intensive care unit in a 20 beds critical 
care unit in at Staten Island University Hospital in New York in 2009. The objective was 
to compare the effectiveness of the use of a new 1-piece CHG transparent gel dressing 
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with a chlorhexidine patch (Biopatch®) in maintaining the low rate of catheter-related 
bloodstream infections in the intensive care unit and to evaluate nurses’ satisfaction with 
and cost of the new dressing. All patients who were admitted in the critical care unit 
requiring central catheters had a CHG gel pad dressing applied. Sixty-two nurses 
participated in placing the CHG gel dressing, and 30 responded to the survey. The study 
revealed that eliminating the Biopatch®, the new CHG gel dressing will have cost saving 
of $3.42 per dressing change. During the study period of 1881 device days, the infection 
rate dropped from 0.052 per 1000 device days in 2008 to 0.0051 per 1000 days in 2009. 
Nurses preferred the new dressing compared to the old dressing, and the new dressing 
had a total cost savings of $3807. Therefore, the new dressing can lead to a lower rate of 
catheter-related bloodstream infections, increase nurses’ satisfaction, and contribute to 
cost savings (Pfaff et al., 2012).  
Karpanen et al., (2015) conducted a clinical trial to evaluate the introduction, 
performance, and clinical staff perceptions of the standard transparent intravenous 
dressing in comparison to the transparent film intravenous line dressing with a CHG gel 
pad at the insertion site of short-term central venous catheters and vascular access 
catheters for dialysis in adult critical care patients. The evaluation involved 273 patients 
in 75 critical care beds in a University Hospital at the city of Birmingham in the UK. 
CHG dressing, (n= 136) and Standard dressing (n= 137). 71 nurses and ten clinicians 
responded to the survey. The staffs were trained and were competent to handle central 
venous catheter per the hospital policy. Questionnaires were used as a form of evaluation 
after 12 months of the use of standard transparent dressing (dressing used in throughout 
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the hospital) and after nine months use of the IV dressing incorporating a CHG gel pad. 
The anonymous questionnaires that were returned in sealed boxes after completion was 
directly distributed to the trained nurses in the critical care and anesthetist in the 
operating theaters who had experience with CVC insertion and competency. The majority 
of the clinical staff (70 out of 81 respondents) considered the performance of the IV 
dressing containing a CHG gel pad better or much better than the standard dressing. 
Seventy seven out of 78 respondents recommended continuing its use. Both types of 
dressing performed better well when applied to the insertion site of IV catheters in the 
internal jugular, subclavian, and femoral care patients (Karpanen et al., 2015).  
Guclu et al., (2014) conducted a before (SP-1) and after clinical trial (SP-2) to 
investigate the efficacy of chlorhexidine-impregnated gel dressings in reducing the 
catheter-related bloodstream infections (CRBSI). The study was conducted between 
January 2010 and December 2011 in a six-bed intensive care unit of a tertiary care 
hospital involving 991 adult patients (521 patients in sterile dry gauze before the study 
and 470 in chlorhexidine-impregnated gel dressings after the study). In the first trial part 
of the study (between January 2010 and December 2010), sterile gauze was used as a 
catheter side dressing and changed every two days unless the dressing became saturated 
or loosened and in the second part of the study period (January 2011 and December 
2011), 2% chlorhexidine-impregnated gel dressings (Tegaderm™ 3M) were used and 
changed every seven days unless needed to be changed before the time. The infection 
control nurse and the infectious disease specialist evaluated patients for hospital-acquired 
infections every morning. Ninety four central venous catheters were inserted for the first 
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study (823 catheter days) and 53 central venous catheters were inserted for the second 
part of the study (560 catheter days). Six and five central-line related bloodstream 
infections were observed in SP-1 and SP-2 respectively (p>0.05). The study concluded 
that although there were decreased numbers of CVC inserted on the SP-2, the incidences 
of CRBSIs between the two periods did not differ (p>0.05) (Guclu et al., 2014).  
Moureau, Deschneau, and Pyrek (2009) conducted a clinical evaluation to 
statistically validate the performance of a new CHG gel dressing in the clinical setting by 
skilled IV nurses and to compare the new CHG gel dressing to the CHG disk in six 
United States hospitals from different states. Sixty four IV nurse’s evaluators participated 
in the clinical evaluation with a total of 500 new CHG gel dressings applied during the 
evaluation period for 73 days. Study sites were selected based on their current use of a 
CHG antimicrobial absorptive foam disk (CHG disk/Biopatch®). Nurses’ evaluators used 
an integrated transparent absorbent CHG gel dressing in place of their current CHG disk 
plus transparent dressing. Each site participated for a period of minimum 14 days, and the 
nurse evaluators completed the questionnaires at the end of the evaluation period. The 
evaluation questions were in 16 levels striated into four performance groups: ease of 
application, gel dressing performance, securement function and other. The new CHG gel 
dressing was rated significantly better than the comparative CHG disk plus transparent 
dressing in overall performance (p<0.0001); 90.5% of evaluators rated the new dressing 
as equal to or better than, the comparative dressing. The new CHG gel dressings were 
evaluated significantly better in all dimensions of performance studied. The study 
concluded that the CHG gel dressing provides antimicrobial activity at the insertion site 
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in an integrated dressing that is easy to use and has a higher level of clinical performance 
and less chance for application error that would lead to better compliance to established 
standards of practice (Moureau et al., (2009). 
Evidence Synthesis 
Reduction of CLABSIs. Different studies demonstrated the efficacy of CHG 
Tegaderm™ gel in the reduction of CLABIs. A meta-analysis of randomized control 
trials study by Safdar and colleagues (2014) reviewed that the use of chlorhexidine-
impregnated dressing results in the reduction of the prevalence of CLABSI. Similarly, 
multiple randomized controlled trials conducted by Timsit et al., (2012) indicated that the 
use of CHG Tegaderm™ gel results in significant reduction of CLABSI counting to 57% 
reduction of the patient with infections and 60% reduction of infection per 1000 catheter 
days while using the CHG gel dressing. In a prospective randomized clinical trial done by 
Karpanen and colleagues (2016) to evaluate the antimicrobial efficacy of the CHG gel in 
patients with CVC, the study revealed a significant reduction of the number of 
microorganisms recovered from CHG gel compared to the standard dressing. In a study 
done by Biehl et al., (2016) to evaluate the efficacy of CHG gel in neutropenic patients 
with CVC, the randomized multicenter trials revealed that the application of CHG gel 
dressing reduces the CRBSI indefinitely. Pedrolo and colleagues (2014) in their 
randomized clinical trial to assess the effectiveness of the chlorhexidine antimicrobial 
dressing in comparison to the gauze and tape dressing revealed no significant differences 
between the two dressing regarding the occurrence of CLABSIs, local reactions to the 
dressing and dressing fixation. Bashir et al., (2012) in their randomized clinical trial study 
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to compare the CHG gel with CHG Biopatch® (disk) revealed that the use of CHG gel is 
essential in the reduction of CLABSI because of the ability to maintain suppression of 
regrowth of bacteria after antisepsis during the central line insertion because the CHG gel 
ensures continuous releasing of CHG. Rupp and colleagues (2008) in their prospective 
randomized single-center controlled trial to assess the clinical performance of innovative 
CHG Tegaderm™ dressing containing CHG gel pad in minimizing the growth of the 
microbes at the catheter insertion site revealed that the use of CHG gel helps to mitigate 
the CLABSI. The Mourea et al., (2009) in their non-randomized clinical trial to evaluate 
the clinical performance of the CHG gel revealed that the dressing provides antimicrobial 
activity at the insertion site compared to the CHG disk. Maki and colleagues (2008) in 
their comparative analysis between CHG Tegaderm™ gel and CHG Biopatch® in a non-
randomized clinical trial revered that the CHG gel dressing provides superior prevention 
of floral regrowth on prepped sites and progressive kill of the cutaneous microflora on 
unprepped sites compared to the CHG sponges (Biopatch®).  
Cost-effectiveness. To assess the cost-effectiveness of the CHG gel, different 
studies were identified that yield the benefit of how economical the CHG gel is in the 
cost reduction. In the meta-analysis study done by Mauoury et al., 2015) using 
multicenter randomized controlled trials, the CHG gel is considered more cost-effective 
than the standard antimicrobial dressing because of the ability to reduce the numbers of 
CLABSI hence reduce the cost associated with CLABSIs. Heiman and colleagues (2012) 
in their clinical controlled trial to evaluate the health economic analysis on the use of 
CHG gel compared to non-CHG dressings revealed that although the overall direct costs 
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of using both dressings are the same, the CHG dressing provides better antimicrobial 
coverage that leads to lower rate of probable CLABSIs that will lead to decreased costs. 
Pfaff et al., 2012 in their quasi-experimental studies to compare the effectiveness of CHG 
gel compared to the CHG Biopatch® revealed that the use of CHG gel is cost-effective in 
the reduction or elimination of CLABSIs compared to the CHG Biopatch®.  
Easiness of use, application, view of the insertion site, and staff satisfaction. 
The use of CHG gel is supported with evidence on the easiness of use, easiness of 
application, easier to view the insertion site and staff satisfaction on its use. For instance, 
Olson and colleagues in their randomized control trial to evaluate the new CHG gel 
Tegaderm™ dressing for its practicality of use in clinical practice on central venous 
devices revealed that the dressing is easy to use in central venous catheter care as the 
standard dressing and it offers more advantages compared to the standard non-
antimicrobial dressing. In their study to evaluate the ease of use of a transparent CHG gel 
dressing versus the CHG disk (Biopatch®), Eyberg and colleagues (2008) using a 
randomized prospective comparative study revealed that the CHG gel dressing is better 
compared to the Biopatch® in regard to its ease of application, ease of applying correctly, 
ease of removal, ability to visualize the insertion site, and ease of training others on how 
to use the CHG gel dressing as a one-step dressing compared to the use of CHG disk 
together with transparent dressing as a two-step dressings. Rupp et al., 2008 in their 
randomized controlled trials to assess the clinical performance of CHG gel dressing 
concluded that the CHG gel dressing is well-tolerated well by the patients with a central 
venous catheter, has better securement and clinicians judge the dressing as more superior 
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and more satisfaction of using it compared to the CHG Biopatch®. Karpanen et al., 2015, 
in their clinical trial to evaluate the performance of the CHG gel dressing in clinical 
environment revealed that the CHG gel is well tolerated and patients whose dressing 
were applied performed excellently in the critical care environment. By evaluating the 
clinical performance of the CHG gel transparent dressing, Mourea et al., 2009 in the 
experimental study concluded that the CHG gel has a more significant clinical 
performance and less chance for application error that would lead to better compliance to 
established standards of practice compared with CHG disk. Maki et al., 2008 in their 
prospective comparative clinical study revealed that the use of CHG gel dressing is more 
superior and advantage to using compared to the CHG Biopatch® in that it is easier to 
apply, secures the catheter and permits continuous inspection of the insertion site because 
it is transparent compared to the Biopatch® which is opaque. Zehrer and colleagues 
(2010) in their clinical trial to of clinicians evaluating the performance of CHG gel to the 
CHG disk (Biopatch®) revealed that clinicians recommended the CHG gel pad dressing 
over the CHG disk due to ease of use and ability to visualize the IV site. Pfaff and 
colleagues (2012) in their experimental study to compare the effectiveness of the CHG 
gel dressing with Biopatch® concluded that the nurses who used the CHG gel were more 
satisfied and preferred using the dressing than using the CHG Biopatch®.  
Impacts on the Findings 
The primary goal of this systematic review was to find whether there is enough 
substantial evidence that can support the intervention of using an adhesive transparent 
CHG gel in the prevention of central-line associated bloodstream infections (CLABISs). 
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Based on the above findings, this systematic review has answered the clinical question or 
practice-focused question formulated before the start of this systematic review because 
they indicated that the adhesive transparent CHG Tegaderm™ gel dressing for the central 
venous catheter is superior compared to the chlorhexidine Biopatch® in decreasing the 
central-line associated bloodstream infections.  
The review of the meta-analysis of the randomized controlled trials, and 
randomized controlled trials, and the non-randomized clinical trials yielded enough 
evidence to support the use of CHG Tegaderm™ gel in place of Biopatch® for the 
central venous catheter. Unlike the Biopatch® that require two steps dressing (Biopatch® 
film/disk covered with transparent adhesive dressing) the CHG Tegaderm™ gel dressing 
is a one-way dressing that incorporates the gel and the dressing, and it makes it easier to 
apply and to use. Unlike the Biopatch® that is opaque and makes it difficult to view the 
insertion site, the use of CHG Tegaderm™ gel makes it easier to see the insertion site and 
makes it easy to monitor in case of any signs of infection.  
The articles reviewed indicated that the use of CHG will be economical because it 
can decrease the rates of CLABSIs that result to cost burden to the patients, facility, and 
the health care at large. Different studies such as meta-analysis of multiple randomized 
trials conducted by Safdar and colleagues (2014) found that the CDC gel has a high 
prevalence of reducing the CLABSIs. Numerous randomized clinical trials such as Timsit 
and colleagues (2012), Karpanen and Colleagues (2016), Biehl and Colleagues (2016), 
Pfaff and colleagues (2012), Eyberge and colleagues (2008), Rupp et al., (2008), and 
Bashir and Colleagues (2012) found that the use of CHG gel is significant in the 
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reduction of CLABSIs compared to the standard antimicrobial transparent dressing, 
gauze or chlorhexidine disk (Biopatch®). Also, different clinical trials such as Moureau 
et al., (2009) found that the use of CHG gel dressing provides antimicrobial activity at the 
insertion site in an integrated dressing that is easy to use. The CHG gel has a more 
significant clinical performance and less chance for application error that would lead to 
better compliance with established standards of practice compared to the CHG disk 
(Biopatch®). 
 Clinical trials such as Heimann et al., (2018) found that although the use of CHG 
gel dressings is expensive, the expenses are outweighing by a lower rate of 
probable/definite CLABSIs and reduced associated costs. Karpanen et al., 2015 while 
evaluating the clinical performance of chlorhexidine gel containing dressing in clinical 
environment found that the CHG gel CVC dressing was well tolerated by patients and 
performed excellently in the critical care environment. Other studies such as a clinical 
trial conducted by Zehler et al., (2010), Olson et al., (2008) to evaluate the performance 
of using CHG gel revealed that clinicians recommended the CHG gel pad dressing over 
the CHG disk due to ease of use, ability to visualize the IV site, and the ability to absorb 
fluid.  
The cost impact of using the CHG gel was also evaluated and multiple studies 
such as the meta-analysis conducted by Maunoury and colleagues (2015) revealed a 
significant decrease in the number of CLABSI using CHG gel that led to the lower cost 
of patients’ care associated by CLABSIs and CLABSIs related conditions. The study by 
Pfaff et al., (2012) revealed that the use of CHG gel was cost-effective compared to the 
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chlorhexidine Biopatch® and it reduces or eliminates the incidence of catheter-related 
bloodstream infections and nurses preferred using the dressing gel compared to the 
chlorhexidine Biopatch®.  
Therefore, the included studies in this systematic review discussed the impact of 
chlorhexidine on the reduction of CLABSIs, its cost-effectiveness, the easiness of its use, 
the ability to continually assess the site of insertion, and the ease to teach others to apply 
the CHG gel. The dressing is widely recommendations by nurses who have previously 
used the CHG disk (Biopatch®) to switch to CHG gel as the dressing is user-friendly and 
more economical.  
Implications for Social Change 
The purpose of conducting this systematic review was to gather, analyze and 
synthesize evidence that will lead to decrease in the numbers of CLABSIs for acute or 
critically ill patients that cause mortality, morbidity, and cost burden to the patients, 
facility and the health care at large. Through the evidence obtained, there is clear 
understanding that implementing the findings of the systematic review and adopting the 
use of CHG Tegaderm gel dressing and other central line care, the number of CLABSIs 
will decrease compared to the use of CHG Biopatch®. The use of CHG Tegaderm gel 
dressing has proven to not only prevents the rates of CLABSI but it is cost effective 
compared to other dressings due to the ability to avoid CLABSIs that can cause huge cost 
burden to the patients’, facility and the health care. By decreasing the rates of CLABSIs, 
the chances of mortality and morbidity that can eliminate the productive members of the 
society are reduced and therefore, it is not only contributing to improve health care, but it 
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is also contributing to the economic aspect of a nation or humankind. The use of this 
systematic review will have a social implication in the local facility if implemented 
because of the already struggling need to reduce the number of CLABSIs despite the 
adherence to the CDC 2011 central line care bundles. By implementing this systematic 
review, the local facility can reach their target of reducing the number of CLABSIs from 
the current rate hence save health care dollars and lives.  
Recommendations 
The products of this systematic review provide a clear evidence that can be 
implemented as a quality improvement project in the care of central venous catheter in a 
facility that is struggling in the reduction of the central-line related bloodstream 
infections. The recommendations are after careful analysis and synthesis of the 
researched articles that proved that the proposed treatment modality (adhesive transparent 
CHG Tegaderm gel dressing) is superior to the use of CHG Biopatch® covered with an 
adhesive transparent dressing. The use of adhesive transparent CHG gel dressing is useful 
when implemented with other central venous catheter care bundles as indicated by the 
CDC 2011 guidelines. The CHG gel dressing provides a clear view of the insertion site 
that is important to monitor when patients have the central venous catheter. For the CHG 
gel dressing to yield results compared to the CHG disk, the usual care and central venous 
standard bundles should be followed as outlined earlier in this study. For the intervention 
to be implemented the management and the leadership should look at the different 
strategies of how to provide clear teaching and enough practices to the end users on how 
to apply for the intervention to be deemed sufficient to achieve the targeted results of 
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reducing the CLABSIs. After implementation, the facility should compare one year 
before the implementation and one year after the implementation regarding cost for the 
dressing, nurses’ evaluation on the usefulness and performance of the dressing and the 
rate of CLABSIs compared with the previous standard dressing used.  
Strengths of the Findings 
The study included larger numbers of randomized controlled trials, clinical 
control trials, and two meta-analyses and excluded levels 4-7 of the Melynk's et al., 
(2011) hierarchy of evidence. Levels 1 and 2 articles are considered the highest level 
evidence, and few articles are level 3 that are clinical trials. The advantages of using level 
1 and 2 are that they have fewer risks of bias because the patients have equal chances to 
be in the intervention and control group due to randomization. Therefore, having multiple 
studies that included either one or multiple randomized controlled trials are clear 
evidence that the intervention is well supported and had been studied and proved to work 
through clinical trials. By use of this systematic review, the local facility and the nursing 
practice can use the study as the guide of evidence and have confidence that changing the 
chlorhexidine Biopatch® to chlorhexidine gel in addition to the standard central line 
bundles care can lead to decrease or lead to zero numbers of CLABSIs. Lowering the 
numbers of CLABSIs will save the health care costs and reduce mortality and morbidity 
associated with CLABSIs or CLABSIs-related illnesses.  
Limitations on Findings 
There is no systematic review found that met criteria for inclusion in this 
systematic review and only two meta-analyses of the randomized controlled trials that 
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were available were included in the study. Only studies that were in the English language 
were included in the study. Studies that were in foreign language and could have 
contributed to this systematic review were excluded due to lack of translator or inability 
to translate. Also, only online published literature was used as a source of evidence for 
the study. Probably some articles in the paper format could have contributed to the study, 
but they were excluded. Articles that were not clear or not discussing the chlorhexidine 
gel dressing were excluded to reduce bias. Articles with a level of evidence 4-7 according 
to the Melynk et al., (2011) were excluded from the studies. The selected number of full 
articles that qualified for the review outnumbered the non-supportive articles, and 
therefore, the impact of non-supportive articles was little on the systematic review. The 
study only included one reviewer that was involved in the whole process of the 
systematic review such as retrieving, reviewing and selecting articles unlike the 
traditional method of more than one reviewer in the systematic review and this could 
create bias.  
My aim of conducting this systematic literature review was to find, retrieve, 
analyze and synthesize the best available evidence to support the use of CHG gel dressing 
in the reduction of central-line associated bloodstream infections in adults in acute or 
critical care units. In this section 4, I identified the method of articles selection, the 
number of articles selected and those that met the inclusion criteria. I also summarized 
the articles identified and discussed the strength and limitations of the study discussed. 
Also, the recommendation for the study was included. Based on the findings, the 
intervention proposed is well supported by the evidence from the meta-analysis, 
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randomized controlled trials, and non-randomized clinical trials. Based on the results of 
this study, there is enough confidence that the management and nursing leadership at the 
local facility can use these findings as the basis for changing the current use of 
Biopatch® covered by adhesive transparent dressing to a dressing that integrates the 
CHG gel to the adhesive transparent dressing. The findings provide enough evidence that 
it reduces the rate of CLABSIs, is cost-effective, is rated high as more effective, easy to 
use, easy to apply and remove and easy to teach others on the use of CHG gel as it is a 
one-step dressing compared to the two steps in the CHG Biopatch®. 
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Section 5: Dissemination Plan 
The gap on the best method to prevent the CLABSIs in patients with central 
venous catheter admitted to the acute and critical care units remains. The purpose of this 
systematic review was to find, retrieve, analyze and synthesize the best available 
evidence from the current published literature that will support the use of adhesive 
transparent CHG gel dressings in the prevention of CLABSIs. The systematic review was 
guided by the logic model that acted as a blueprint by steering in the formulation of the 
practice-focused question, set the inclusion criteria, conduct in the retrieval of evidence, 
summarize them and make the conclusion of whether the evidence answered the practice-
focused question to achieve the desired outcomes.  
The results of this systematic review indicated that there is clear evidence that the 
use of the proposed treatment modality, if implemented besides other central line care 
bundles, will drastically reduce the rate of CLABSIs. It will also lead to a decrease in the 
highest cost that the facilities bare when a CLABSI is diagnosed as it is considered a non-
reimbursed nosocomial infection. Not only does it reduce the unnecessary costs to the 
facility but will also reduce the health care cost burden and save lives. This review will 
be provided to the local facility nursing leadership for evaluation and dissemination. The 
review will include the background information, evidence from literature, the summary 
of the evidence and the recommendations. The information in this review will be 
presented through a power point presentation, handouts or printouts to the appropriate 
management and leadership and the nursing services. The implementation of the 
proposed treatment intervention will be recommended so that the organization can 
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receive the benefits and the goal target of reducing the CLABSIs rate. Due to the highest 
level of evidence obtained and having clinical trials and randomized clinical trials 
conducted in different settings both nationally and internationally, the potential for other 
health care organizations to use the data from this systematic review could also provide 
insights and benefits in the reduction or bring to probable zero the deadly hospital-
acquired disease called CLABSI. Also, further research or systematic review and meta-
analysis on the application of CHG gel dressing could bear more fruits in future. 
Audiences and Venues Appropriate for Dissemination 
My purpose of conducting this integrative review was to search and retrieve an 
extensive literature to support a treatment modality that is considered superior in the 
prevention of CALBSIs in acute and critical care units. Due to the needs of daily use of 
the CVC for medications, food, fluid or hemodynamic monitoring, the risk of patients 
developing CLABSI increases. As a dressing that is not widely being used, proper 
audiences to disseminate and present the findings of the systematic review will be local 
acute and critical care units and other nursing organizations such as the American 
Association of Critical Care nurses and doctors, as well as the American Nurses 
Association during their conferences. 
Analysis of Self  
My journey through the DNP program at Walden University began in May 2017 
as a continuation of my Master of Science in nursing to achieve my lifetime dream goals. 
The journey has not been easy, but with the aspiration, hardworking, perseverance and 
determination I can testify that everything is possible once you set your eyes on it. During 
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the process of conducting this systematic review, my knowledge on how to turn research 
into evidence has been harnessed. My hopes for the future are to be a significant 
contributor in the field of nursing as a scholar and a mentor to others going through the 
process of the doctoral studies. As a previous staff nurse in the critical care unit, I have 
taken care of patients diagnosed with CLABSI despite the meticulous application of the 
2011 CDC guidelines in the care of central venous catheter, and some led to mortality or 
increased hospital stay, and this broke my heart. Therefore, having a project that is 
tailored to the prevention and decrease of the rate of CLABSIs is both personally and 
professionally fulfilling. As a doctoral prepared nurse, the hallmark of the doctoral 
education is demonstrating the ability to critically appraise available literature and 
evidence and implement it as an evidence-based practice. I articulated that by conducting 
this extensive integrative literature review, I have mastered the American Association of 
Colleges of Nursing DNP Essential III: Clinical Scholarship and Analytical Methods for 
Evidence-based Practice (American Association of Colleges of Nursing, 2006).  
As a doctoral-prepared nurse, I will be at the forefront to use the skills attained 
during my doctoral studies. By conducting this systematic review, the findings will be 
used to support facilities and nursing practice in the quality improvement programs to 
improve patients’ outcomes. As a result of conducting this doctoral project, I have 
harnessed my knowledge and ability in searching and retrieving evidence from literature 
and analyzing the evidence to solve simple and complex clinical problems. Moreover, my 
professional goals have been tailored to be a scholar, mentor, and educator. I will use my 
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knowledge and experience gained during this doctoral journey to improve nursing 
practice and my professional growth. 
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Summary 
CLABSI is an infection that occurs within 48 hours of central line placement. 
CLABSIs are considered the costliest HAIs. CLABSIs are preventable if the right care 
and measures are taken. The CDC has CVC care guidelines, but the guidelines are not 
rigid on the dressing to be used during the CVC care. Traditionally, the CHG Biopatch® 
covered with adhesive transparent dressing has been used as CLABSI prevention 
measures together with the CDC guidelines. In spite of facilities adhering to the CDC 
guidelines in addition to the use of Biopatch® covered with an Adhesive transparent 
dressing, the rate of CLABSI continues to rise.  
In Section 1 of this doctoral review, I discussed the nature of the project by 
identifying the project question, the nature of the study, and the importance of the 
proposed treatment modality. In this case, the purpose of this systematic review was to 
conduct an integrative review of the literature on the use of adhesive transparent CHG 
Tegaderm™ dressing in the prevention of CLABSI. The dressing is a new one method 
dressing which is composed of an adhesive transparent Tegaderm™ with CHG gel that 
releases the CHG continuously and allows the view of the insertion site, unlike the 
Biopatch® which is opaque and requires the disk to be covered by an adhesive 
transparent dressing making it a two way process. A predefined PICOT question was 
formulated that guided the review as well as the inclusion and exclusion criteria.  
In Section 2, I discussed the background the context of the doctoral project. A 
framework that guided this systematic review was logic model, which is considered as a 
roadmap and guided the whole systematic review from identifying the inclusions criteria 
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to retrieving the evidence and determine the outcomes from the findings if implemented. 
The role of the project in the nursing practice was discussed and how the student as a 
project manager contributed from the start to finish of the review. The reason why the 
project is carried due to the needs at the local facility was discussed and how the findings 
will impact the care and improve patients’ outcome locally and in nursing practice. 
In Section 3, the review discusses how the evidence was collected and 
synthesized. The review discusses the steps to conduct the retrieval of evidence by first 
contacting the university review board, and after the approval as a preapproved for DNP 
project; the student conducted an extensive data search. Different databases such as the 
Cochrane, PUBMED, EMBASE, CINAHL, MEDLINE, ProQuest Nursing, and Google 
Scholar were used to find and retrieve the published literature to support the hypothesis 
of the predefined practice question. By thoroughly and extensively searching the above 
databases and google scholar, 373 articles were retrieved and assessed fully to identify 
the articles that met the criteria based on the predefined inclusion criteria. A total of 16 
articles qualified for the final review by meeting the criteria and 11 full articles assessed 
did not meet the criteria. The articles that met the criteria were graded using the Melynk 
and Fineout-Overholt hierarchy level of evidence. 
 In Section 4, I discussed the findings and the recommendation of the systematic 
review of the literature. I broke down the evidence synthesis into how effective the CHG 
gel Tegaderm™ is effective in the reduction of CLABSI, how economical is the CHG gel 
Tegaderm™ and how easier it is to use the CHG gel Tegaderm™ compared to the 
Biopatch® with an adhesive transparent dressing. Based on the findings of the literature 
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review, the use of CHG gel dressing is core in the fight to reduce the rate of the deadly 
CLABSIs. Due to the strength of findings from meta-analysis and single and multiple 
randomized controlled trials, the use of CHG Tegaderm™ gel is well supported by the 
literature as an effective method of controlling CLABSI, reducing health care burdens 
and reducing mortality and morbidity associated with CLABSI or CLABSI-related 
illnesses.  
In Section 5, I discussed the dissemination plan. I explained the appropriate 
audiences that will benefit from the findings of the review such as the local acute care 
critical care units, National nursing associations such as the American Association of 
Critical care Nurses and the American Nurses Association. 
In conclusion, the process of conducting this review has been personally and 
professionally fulfilling. The doctoral program and the process of conducting this 
systematic review have helped me to improve on how to turn research into practice in 
solving complex nursing issues and how to improve patients’ outcomes. It is my plan to 
continue building my professional journey as a mentor, teacher, scholar, and practitioner.  
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